Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review

Mascolo A, Scavone C, Rafaniello C, Ferrajolo C, Racagni G, Berrino L, Paolisso G, Rossi F, Capuano A.

Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19

Cadegiani FA, Wambier CG, Goren A.

DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

Smelcerovic A, Kocic G, Gajic M, Tomovic K, Djordjevic V, Stankovic-Djordjevic D, Anderluh M.

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?

Valencia I, Peiró C, Lorenzo Ó, Sánchez-Ferrer CF, Eckel J, Romacho T.

Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis

Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM.

Cardiovascular Diseases (CVDs) in COVID-19 Pandemic Era

Gerc V, Masic I, Salihefendic N, Zildzic M.

Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report

Faqihi F, Alharthy A, Alshaya R, Papanikolaou J, Kutsogiannis DJ, Brindley PG, Karakitsos D.

Electrocardiographic signs of acute right ventricular hypertrophy in patients with COVID-19 pneumonia: A clinical case series

Martínez-Mateo V, Fernández-Anguita MJ, Paule A.

A Novel Protocol for Very Early Hospital Discharge following STEMI

Marbach JA, Alhassani S, Chong AY, MacPhee E, Le May M.

Primary Percutaneous Coronary Intervention or Fibrinolytic therapy in COVID 19 Patients Presenting with ST- Segment Elevation Myocardial Infarction

Sudhakar D, Jneid H, Lakkis N, Kayani WT.

Surge in Delayed Myocardial Infarction Presentations: An Inadvertent Consequence of Social Distancing During the COVID-19 Pandemic

Shah K, Tang D, Ibrahim F, Ghosh B, Bhatti S, Akhabue E, Vagaonescu T, Zakir R, Hakeem A.

Acute Myocardial Infarction and Papillary Muscle Rupture in the COVID-19 Era

Atreya AR, Kawamoto K, Yelavarthy P, Arain MA, Cohen DG, Wanamaker BL, El Ela AA, Romano MA, Grossman PM.

Delayed Presentation of STEMI Complicated by Ventricular Septal Rupture in the Era of COVID-19 Pandemic

Ahmed T, Nautiyal A, Kapadia S, Nissen SE.

Hydroxychloroquine is protective to the heart, not Harmful: A systematic review

Prodromos CC.

Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in Australia

Climie RE, Wu JHY, Calkin AC, Chapman N, Inglis SC, Mirabito Colafella KM, Picone DS, Tan JTM, Thomas E, Viola HM, Wise SG, Murphy AJ, Nelson MR, Nicholls SJ, Hool LC, Doyle K, Figtree GA, Marques FZ; Australian Cardiovascular Alliance.

STEMI and COVID-19 Pandemic in Saudi Arabia

Daoulah A, Hersi AS, Al-Faifi SM, Alasmari A, Aljohar A, Balghith M, Alshehri M, Youssef AA, ElSayed O, Alama MN, Refaat WA, Alzahrani B, Dahdouh Z, Khan AS, Ghani MA, Soofi MA, Alasnag M, Kazim HM, Elganady A, Hassan T, Ibrahim AM, Amellal Z, Alsmadi F, Ghazi AM, Alshehri AM, Alhulayfi MS, Ghonim AA, Algazzar AS, Al Garni TA, AlHarbi W, Jouda AA, Al-Shaibi K, Albasiri S, Abuelatta R, Tawfik W, Magdy M, Alasmari SR, Selim E, Elramly M, Abufayyah MA, Alshahrani SS, Alqahtani AH, Ahmed FA, Ahmed W

Rhythm, Conduction and ST elevation with COVID-19: Myocarditis or Myocardial Infarction?

Mansoor A, Chang D, Mitra R.

State-of-the-Art review: Hypertension practice guidelines in the era of COVID-19

Ferdinand KC, Vo TN, Echols MR.

Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology

Khera A, Baum SJ, Gluckman TJ, Gulati M, Martin SS, Michos ED, Navar AM, Taub PR, Toth PP, Virani SS, Wong ND, Shapiro MD.

Management of Acute Coronary Syndrome in the COVID-19 Era: Voices From the Global Cardiology Community

Gambaro A, Ho HH, Kaier TE, Pires-Morais G, Patel JA, Ansari Ramandi MM.

The Hidden Victims of the COVID-19 Pandemic: Congenital Heart Disease Patients

El-Saiedi SA, Haeffele C, Hanna BM, Lui GK.

4 Cases of Aortic Thrombosis in Patients With COVID-19

Woehl B, Lawson B, Jambert L, Tousch J, Ghassani A, Hamade A.

Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team

Sethi SS, Zilinyi R, Green P, Eisenberger A, Brodie D, Agerstrand C, Takeda K, Kirtane AJ, Parikh SA, Rosenzweig EB.

Shared Decision Making in Cardiac Transplantation During the COVID-19 Pandemic: Patient Refusal of Transplantation

Chaudhry SP, Salerno CT, Ravichandran AK, Walsh MN.

Stress-Induced Cardiomyopathy Precipitated by COVID-19 and Influenza A Coinfection

Sang CJ 3rd, Heindl B, Von Mering G, Brott B, Kopf RS, Benson PV, Rajapreyar I.

Complete Heart Block, Severe Ventricular Dysfunction, and Myocardial Inflammation in a Child With COVID-19 Infection

El-Assaad I, Hood-Pishchany MI, Kheir J, Mistry K, Dixit A, Halyabar O, Mah DY, Meyer-Macaulay C, Cheng H.

Severe COVID-19 After Recent Heart Transplantation Complicated by Allograft Dysfunction

Vilaro J, Al-Ani M, Manjarres DG, Lascano JE, Cherabuddi K, Elgendy AY, Bleiweiss MS, Parker AM, Ahmed MM, Aranda JM Jr.

Feasibility of Prone Position Coronary Angiography in a Patient With COVID-19 Pneumonia and Refractory Hypoxemia

Mangiameli A, Bendib I, Martin AS, Razazi K, Teiger E, Gallet R.

Acute Multivessel Coronary Occlusion Revealing COVID-19 in a Young Adult

Zendjebil S, Zeitouni M, Batonga M, El Bèze N, Guedeney P, Collet JP, Choussat R, Silvain J, Montalescot G.

Acute Increase in Deaths Among Patients With Adult Congenital Heart Disease During COVID-19: Single-Center Experience

Dawson KL, Vincent LL, Krieger EV, Stout KK, Buber J.

Cardiac Dysfunction and Shock in Pediatric Patients With COVID-19

Joshi K, Kaplan D, Bakar A, Jennings JF, Hayes DA, Mahajan S, Misra N, Mitchell E, Sweberg TM, Taylor MD, Capone CA.

The COVID-19 Pandemic and Cardiovascular Complications: What Have We Learned So Far?

Walsh MN, Sorgente A, Fischman DL, Bates ER, Grapsa J.

Starting My Career as a Cardiologist During COVID-19

Giblett JP.

Collateral Damage: Medical Care Avoidance Behavior Among Patients With Myocardial Infarction During the COVID-19 Pandemic

Moroni F, Gramegna M, Ajello S, Beneduce A, Baldetti L, Vilca LM, Cappelletti A, Scandroglio AM, Azzalini L.

Complication of Late Presenting STEMI Due to Avoidance of Medical Care During the COVID-19 Pandemic

Otero D, Singam NSV, Barry N, Raheja P, Solankhi A, Solankhi N.

Subacute Left Ventricular Free Wall Rupture after Delayed STEMI Presentation During the COVID-19 Pandemic

Albiero R, Seresini G.

Ventricular Septal Rupture Complicating Delayed Acute Myocardial Infarction Presentation During the COVID-19 Pandemic

Alsidawi S, Campbell A, Tamene A, Garcia S.

The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection

Sainz-Cort A, Heeroma JH.

Severe COVID-19 with debut as bilateral pneumonia, ischemic stroke, and acute myocardial infarction

García Espinosa J, Moya Sánchez E, Martínez Martínez A.

Acute pericarditis due to COVID-19 infection: An underdiagnosed disease?

Tung-Chen Y.

Targeting of renin-angiotensin system in COVID-19 patients affected by stroke: Emerging concerns about detrimental vs. benefit effect

Luzzi S, Giotta Lucifero A, Marasco S, Del Maestro M, Bellantoni G, Gragnaniello C.

[Decrease in ST-segment elevation myocardial infarction admissions in Catalonia during the COVID-19 pandemic]

Romaguera R, Ribera A, Güell-Viaplana F, Tomás-Querol C, Muñoz-Camacho JF, Agudelo V; en representación de los investigadores del Codi IAM.

[Clinical course of COVID-19 in pulmonary arterial hypertension patients]

Nuche J, Pérez-Olivares C, Segura de la Cal T, Jiménez López-Guarch C, Arribas Ynsaurriaga F, Escribano Subías P.

[The presence of heart disease worsens prognosis in patients with COVID-19]

San Román JA, Uribarri A, Amat-Santos IJ, Aparisi Á, Catalá P, González-Juanatey JR.

[Electrocardiographic/QT interval monitoring with a portable device in hospitalized patients with COVID-19: a protocol proposal]

Torres González N, Álvarez Acosta L, Iriarte Plasencia A, Barreto Cáceres V, Valdivia Miranda D, Hernández Afonso JS.

[Arterial thrombotic complications in hospitalized patients with COVID-19]

Rey JR, Caro-Codón J, Poveda Pineda D, Merino JL, Iniesta ÁM, López-Sendón JL; investigadores CARD-COVID.

[COVID-19 quarantine and acute pulmonary embolism]

Vannini L, Llanos Gómez JM, Quijada-Fumero A, Fernández Pérez AB, Hernández Afonso JS.

[Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography]

Marsico S, Espallargas Giménez I, Carbullanca Toledo SJ, Del Carpio Bellido LA, Maiques Llácer JM, Zuccarino F.

[Fatal outcome of COVID-19 disease in a 5-month infant with comorbidities]

Climent FJ, Calvo C, García-Guereta L, Rodríguez-Álvarez D, Buitrago NM, Pérez-Martínez A.

[Pulmonary embolism in COVID-19. When nothing is what it seems]

Ioan AM, Durante-López A, Martínez-Milla J, Pérez-Calvo C, Santos A.

A Case Series of Devastating Intracranial Hemorrhage During Venovenous Extracorporeal Membrane Oxygenation for COVID-19

Usman AA, Han J, Acker A, Olia SE, Bermudez C, Cucchiara B, Mikkelsen ME, Wald J, Mackay E, Szeto W, Vernick WJ, Gutsche JT.

Using Simulation to Assess Cardiology Fellow Performance of Transthoracic Echocardiography: Lessons for Training in the COVID-19 Pandemic

Singh K, Chandra A, Lonergan K, Bhatt A.

Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China

Xiang D, Xiang X, Zhang W, Yi S, Zhang J, Gu X, Xu Y, Huang K, Su X, Yu B, Wang Y, Fang W, Huo Y, Ge J.

Extensive Aortic Thrombosis in a Patient With COVID-19

Katchanov J, Kalisch J, Herzing W, Knorr F, Havla M, Klink T, Dommke C.

SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome

Dolhnikoff M, Ferreira Ferranti J, de Almeida Monteiro RA, Duarte-Neto AN, Soares Gomes-Gouvêa M, Viu Degaspare N, Figueiredo Delgado A, Montanari Fiorita C, Nunes Leal G, Rodrigues RM, Taverna Chaim K, Rebello Pinho JR, Carneiro-Sampaio M, Mauad T, Ferraz da Silva LF, Brunow de Carvalho W, Saldiva PHN, Garcia Caldini E.

Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients

Li C, Jiang J, Wang F, Zhou N, Veronese G, Moslehi JJ, Ammirati E, Wang DW.

A case of broken heart syndrome via the telephone: socially distant outpatient clinics in the COVID-19 pandemic

Parker J, Niranjan S, Sriram KB.

COVID-19 infection in left ventricular assist device patients

Piperata A, Bottio T, Gerosa G.

Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases?

Mansueto G, Niola M, Napoli C.

Quantification of Death Risk in Relation to Sex, Pre-Existing Cardiovascular Diseases and Risk Factors in COVID-19 Patients: Let's Take Stock and See Where We Are

Moula AI, Micali LR, Matteucci F, Lucà F, Rao CM, Parise O, Parise G, Gulizia MM, Gelsomino S.

Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients

Tsolaki V, Zakynthinos GE, Mantzarlis K.

Relative bradycardia in patients with coronavirus disease 2019 (COVID-19)

Capoferri G, Osthoff M, Egli A, Stoeckle M, Bassetti S.

Bradyarrhythmias in patients with COVID-19: A case series

Gupta MD, Qamar A, Mp G, Safal S, Batra V, Basia D, Mandal SK, Yusuf J, Mukhopadhyay S, Bansal A.

Implications for the Care of Patients With COVID-19 and Inflammatory Myocardial Disease-Reply

Inciardi RM, Lupi L, Metra M.

Implications for the Care of Patients With COVID-19 and Inflammatory Myocardial Disease

Di Tano G, Iacovoni A, De Maria R.

Brady-arrhythmias in Patients with COVID-19: Marker of Poor Prognosis?

Chinitz JS, Goyal R, Harding M, Veseli G, Gruberg L, Jadonath R, Maccaro P, Gandotra P, Ong L, Epstein LM.

COVID-19-associated aortic arch thrombus

Mosbahi S, Heinisch PP, Schoenhoff FS, Berger DC.

Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study

Matsuzawa Y, Ogawa H, Kimura K, Konishi M, Kirigaya J, Fukui K, Tsukahara K, Shimizu H, Iwabuchi K, Yamada Y, Saka K, Takeuchi I, Hirano T, Tamura K.

COVID-19 and the burning issue of drug interaction: never forget the ECG

Sciaccaluga C, Cameli M, Menci D, Mandoli GE, Sisti N, Cameli P, Franchi F, Mondillo S, Valente S.

Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology: Endorsed by the American College of Cardiology

Lakkireddy DR, Chung MK, Deering TF, Gopinathannair R, Albert CM, Epstein LM, Harding CV, Hurwitz JL, Jeffery CC, Krahn AD, Kusumoto FM, Lampert R, Mansour M, Natale A, Patton KK, Seiler A, Shah MJ, Wang PJ, Russo AM.

Fatal Post-Infarction Late Left Ventricular Free Wall Rupture in the Era of COVID-19

Kassimis G, Karagiannidis E, Triantafyllou K, Karapanagiotidis GT.

Excess Cardiac Arrest in the Community During the COVID-19 Pandemic

Holland M, Burke J, Hulac S, Morris M, Bryskiewicz G, Goold A, McVaney K, Rappaport L, Stauffer BL.

Shifting Paradigms in Cardiovascular Therapeutic Strategies During the COVID-19 Era

Kornowski R.

Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes

Robinson EL, Alkass K, Bergmann O, Maguire JJ, Roderick HL, Davenport AP.

Implications of ABO blood group in hypertensive patients with covid-19

Sardu C, Marfella R, Maggi P, Messina V, Cirillo P, Codella V, Gambardella J, Sardu A, Gatta G, Santulli G, Paolisso G.

A case of novel coronavirus (COVID-19)-induced viral myocarditis mimicking a Takotsubo cardiomyopathy

Khalid Y, Dasu N, Dasu K.

Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?

Stevenson A, Kirresh A, Conway S, White L, Ahmad M, Little C.

Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19

Stefanini GG, Chiarito M, Ferrante G, Cannata F, Azzolini E, Viggiani G, De Marco A, Briani M, Bocciolone M, Bragato R, Corrada E, Gasparini GL, Marconi M, Monti L, Pagnotta PA, Panico C, Pini D, Regazzoli D, My I, Kallikourdis M, Ciccarelli M, Badalamenti S, Aghemo A, Reimers B, Condorelli G; Humanitas COVID-19 Task Force.

Acute pericarditis as a primary presentation of COVID-19

Kumar R, Kumar J, Daly C, Edroos SA.

Acute perimyocarditis with cardiac tamponade in COVID-19 infection without respiratory disease

Dalen H, Holte E, Guldal AU, Hegvik JA, Stensaeth KH, Braaten AT, Mj√∏lstad OC, Rossvoll O, Wiseth R.

COVID-19, the heart and returning to physical exercise

Kennedy FM, Sharma S.

Increased cardiovascular death rates in a COVID-19 low prevalence area

Del Pinto R, Ferri C, Mammarella L, Abballe S, Dell'Anna S, Cicogna S, Grassi D, Sacco S, Desideri G.

COVID-19 Infection and Cardiac Arrhythmias

Manolis AS, Manolis AA, Manolis TA, Apostolopoulos EJ, Papatheou D, Melita H.

Incidence and impact of cardiac arrhythmias in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Pranata R, Huang I, Raharjo SB.

Myocardial Injury in COVID-19: a Challenge for Clinical Cardiologists

Aragão RCA, Alves MC, Passos HD, Gonçalves LFG, Baumworcel L, Barreto Filho JAS.

Cardiovascular Imaging and Interventional Procedures in Patients with Novel Coronavirus Infection

Costa IBSDS, Rochitte CE, Campos CM, Barberato SH, Oliveira GMM, Lopes MACQ, Nomura CH, Abizaid AA, Cerri G, Kalil Filho R, Hajjar LA.

The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients

Marcello A, Civra A, Milan Bonotto R, Nascimento Alves L, Rajasekharan S, Giacobone C, Caccia C, Cavalli R, Adami M, Brambilla P, Lembo D, Poli G, Leoni V.

Temporal trends in decompensated heart failure and outcomes during COVID-19: A multisite report from heart failure referral centres in London

Cannata A, Bromage DI, Rind IA, Gregorio C, Bannister C, Albarjas M, Piper S, Shah AM, McDonagh TA.

Interplay of COVID-19 and cardiovascular diseases in Africa: an observational snapshot

Chakafana G, Mutithu D, Hoevelmann J, Ntusi N, Sliwa K.

Reopening echocardiography services to care for our patients, including the COVID-19 patient population

Ignatowski D, Umland M, Khandheria BK.

Exercise-based cardiac rehabilitation in COVID-19 times: one small step for health care systems, one giant leap for patients

Ribeiro F, Santos M.

Impact of the COVID-19 pandemic on acute coronary syndrome and stroke volumes in non-Western countries

Boukhris M, Azzalini L, Baystrukov V, Aloui H, Kretov E, Ribeiro MH, Araujo GN, Wainstain MV, Hillani A, Masson JB, Mansour S, Nasri A, Sestier M, Moritz JLW, Julien EJS, Souissi S, Addad F.

COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China

Ranard LS, Parikh SA, Kirtane AJ.

Obstructive sleep apnea, renin-angiotensin system, and COVID-19: possible interactions

Ekiz T, İnönü Köseoğlu H, Pazarlı AC.

Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?

Namsolleck P, Moll GN.

Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19

Megaly M, Glogoza M.

Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients

Chen C, Wang F, Chen P, Jiang J, Cui G, Zhou N, Moroni F, Moslehi JJ, Ammirati E, Wang DW.

Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19

Xu H, Hou K, Xu R, Li Z, Fu H, Wen L, Xie L, Liu H, Selvanayagam JB, Zhang N, Yang Z, Yang M, Guo Y.

Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach

Sperotto F, Friedman KG, Son MBF, VanderPluym CJ, Newburger JW, Dionne A.

Echocardiographic characteristics of patients with SARS-CoV-2 infection

Stöbe S, Richter S, Seige M, Stehr S, Laufs U, Hagendorff A.

Cardiovascular and cardiometabolic prevention: high-level priority in the era of COVID-19

Dhindsa D, Wong ND, Sperling L.

Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complications

AbdelMassih AF, Ramzy D, Nathan L, Aziz S, Ashraf M, Youssef NH, Hafez N, Saeed R, Agha H.

Hypertension and diabetes mellitus in patients with COVID 19: a viewpoint on mortality

Tascioglu D, Yalta K, Yetkin E.

An Atypical Presentation of Fulminant Myocarditis Secondary to COVID-19 Infection

Richard I, Robinson B, Dawson A, Aya A, Ali R.

Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review

Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G.

Women's perspective on the COVID-19 pandemic: Walking into a post-peak phase

Sabatino J, Moscatelli S, Rustamova Y, Kotlar I, Avesani M, Brida M, Gök G, Borrelli N, Marchenko O, Calvieri C, Czerwińska-Jelonkiewicz K, Moharem-Elgamal S, Grapsa J, Öz TK; Pink International Young Academy of Cardiology.

In-hospital Use of ACEI/ARB is associated with lower Risk of Mortality and Critic Illness in COVID-19 Patients with Hypertension: ACEI/ARB protect COVID-19 patients

Yuan Y, Liu D, Zeng S, Wang S, Xu S, Wang Y, Yu R, Gao Y, Li H, Feng X, Zhou N, Zhao C, Gao Q.

Previous cardiovascular surgery significantly increases the risk of developing critical illness in patients with COVID-19

Zhang B, Liu S, Zhang L, Dong Y, Zhang S.

Acute Aortic Thrombosis Revealing a COVID-19 Infection

Coscas R, Coggia M.

Implications of AB0 blood group in hypertensive patients with covid-19

Sardu C, Marfella R, Maggi P, Messina V, Cirillo P, Codella V, Gambardella J, Sardu A, Gatta G, Santulli G, Paolisso G.

Anesthesia for Patients Undergoing Anesthesia for Elective Thoracic Surgery During the COVID-19 Pandemic: A Consensus Statement From the Israeli Society of Anesthesiologists

Shaylor R, Verenkin V, Matot I.

A Portable Negative Airflow Box to Control Exposure for Aerosol-Generating Procedures During Coronavirus Disease 2019 (COVID-19) Pandemic

Cárdenas-Mancera J, Valencia-Arango L, Segura-Salguero JC, Díaz-Bohada L.

D-dimer and right ventricular abnormalities as prognostic factors in critically ill COVID-19 patients

Gonzalez-Fernandez O, Ponz de Antonio I, Rosillo Rodriguez SO, Ruiz Cantador J, Figueira Iglesias JC, Lopez-Sendon Hentschel JL.

Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic

Kow CS, Hasan SS.

Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis

Sabatino J, De Rosa S, Di Salvo G, Indolfi C.

Heart rate reactivity to acute psychological stress predicts higher levels of PTSD symptoms during the COVID-19 pandemic

Ginty AT, Young DA, Tyra AT, Hurley PE, Brindle RC, Williams SE.

Indirect implications of COVID-19 prevention strategies on non-communicable diseases : An Opinion Paper of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk Assessment in Subjects Living in or Emigrating from Low Resource Settings

Modesti PA, Wang J, Damasceno A, Agyemang C, Van Bortel L, Persu A, Zhao D, Jarraya F, Marzotti I, Bamoshmoosh M, Parati G, Schutte AE.

Overcoming Fears to Save Lives: COVID-19 and the Threat to Bystander CPR in Out of Hospital Cardiac Arrest

Perman SM.

Genetic Associations with Plasma ACE2 Concentration: Potential Relevance to COVID-19 Risk

Nelson CP, Sama IE, Codd V, Webb TR, Ye S, Lang CC, Voors AA, Ng LL, Samani NJ.

Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2-Mediated Myocarditis

Tucker NR, Chaffin M, Bedi KC Jr, Papangeli I, Akkad AD, Arduini A, Hayat S, Eraslan G, Muus C, Bhattacharyya RP, Stegmann CM; Human Cell Atlas Lung Biological Network, Margulies KB, Ellinor PT; Human Cell Atlas Lung Biological Network Consortium Members.

Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering from Coronavirus Disease in Wuhan, China

Peng Y, Meng K, He M, Zhu R, Guan H, Ke Z, Leng L, Wang X, Liu B, Hu C, Ji Q, Keerman M, Cheng L, Wu T, Huang K, Zeng Q.

Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia

Di Tano G, De Maria R, Loffi M, Moschini L, Galeazzi G, Danzi GB.

ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub

Gramegna M, Baldetti L, Beneduce A, Pannone L, Falasconi G, Calvo F, Pazzanese V, Sacchi S, Pagnesi M, Moroni F, Ajello S, Melisurgo G, Agricola E, Camici PG, Scandroglio AM, Landoni G, Ciceri F, Zangrillo A, Cappelletti AM.

[COVID-19 and the impact of cardiovascular comorbidities]

Seoudy H, Frey N.

Outcomes of patients diagnosed with COVID-19 in the early postoperative period following cardiac surgery

Yates MT, Balmforth D, Lopez-Marco A, Uppal R, Oo AY.

Defining heart disease risk for death in COVID-19 infection

Li J, Guo T, Dong D, Zhang X, Chen X, Feng Y, Wei B, Zhang W, Zhao M, Wan J.

Cardiac tamponade in COVID-19 patients: Management and outcomes

Hakmi H, Sohail A, Brathwaite C, Ray B, Abrol S.

Early respiratory outcomes following cardiac surgery in patients with COVID-19

Barkhordari K, Khajavi MR, Bagheri J, Nikkhah S, Shirzad M, Barkhordari S, Kharazmian K, Nosrati M.

How to guarantee safety and optimal surgical view in COVID time

Romagnoni C, Contino M, Rosa R, Mangini A.

The impact of COVID-19 pandemic on congenital heart surgery practice: An alarming change in demographics

Korun O, Yurdakök O, Arslan A, Çiçek M, Selçuk A, Kılıç Y, Altın F, Şaşmazel A, Aydemir NA.

Enhancement in virtual learning cannot substitute for hands-on training in cardiothoracic surgery

Villamizar N, Nguyen DM.

International study on impact of COVID-19 on cardiac and thoracic aortic aneurysm surgery

Idhrees M, Bashir M, Mousavizadeh M, Hosseini S.

Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device

Hodges K, Mubashir M, Insler J, Estep J, Hsich E, Tong M, Insler S, Soltesz E.

The utility of bedside echocardiography in critically ill COVID-19 patients: Early observational findings from three Northern New Jersey hospitals

Vasudev R, Guragai N, Habib H, Hosein K, Virk H, Goldfarb I, Bikkina M, Shamoon F, Pullatt R.

Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality

Li G, Saguner AM, An J, Ning Y, Day JD, Ding L, Waintraub X, Wang J.

Immersive technologies as a solution for general data protection regulation in Europe and impact on the COVID-19 pandemic

Proniewska K, Pręgowska A, Dołęga-Dołęgowski D, Dudek D.

COVID-19 Associated Pneumonia and Pleural Effusion Masquerading as Heart Failure in Rheumatic Heart Disease

Malik J, Javed N, Naeem H, Sattar RA, Ikram U.

Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review

Patel J, Patel R, Rodriguez LM, Blanco A, Hamza A.

The renin angiotensin aldosterone system and COVID-19

Alsufyani HA, Docherty JR.

The Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-like Syndrome in Adults: Overlapping Manifestations of COVID-19

Most ZM, Hendren N, Drazner MH, Perl TM.

Serious Concerns About the RCT Study Quality of Traditional Chinese Medicine Injections for Treating Cardiovascular Diseases and COVID-19

Gao G, Leung SW, Jia Y.

Correction to: Off‚Äëthe‚Äëshelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID‚Äë19) pandemic

Scheller B, Vukadinovic D, Link A, Ewen S, Mahfoud F.

Having Coronavirus Disease 2019 (COVID-19)

Shapiro JM.

COVID-19: A New Challenge in Pregnancy and Heart Disease

Avila WS, Carvalho RC.

What Kind of Evidence Is Needed to Dictate Practice Regarding Inhibitors of the Renin-Angiotensin System in COVID-19?

Elijovich F, Laffer CL.

ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2

Sharma RK, Stevens BR, Obukhov AG, Grant MB, Oudit GY, Li Q, Richards EM, Pepine CJ, Raizada MK.

Role of the renin angiotensin system in the development of severe COVID-19 in hypertensive patients

Silva-Aguiar RP, Peruchetti DB, Rocco PRM, Schmaier AH, Silva PMR, Martins MA, Carvalho VF, Pinheiro AAS, Caruso-Neves C.

COVID-19 among heart transplant recipients in Germany: a multicenter survey

Rivinius R, Kaya Z, Schramm R, Boeken U, Provaznik Z, Heim C, Knosalla C, Schoenrath F, Rieth A, Berchtold-Herz M, Barten MJ, Rauschning D, Mücke VT, Heyl S, Pistulli R, Grinninger C, Hagl C, Gummert JF, Warnecke G, Schulze PC, Katus HA, Kreusser MM, Raake PW.

Indications for and Findings on Transthoracic Echocardiography in COVID-19

Jain SS, Liu Q, Raikhelkar J, Fried J, Elias P, Poterucha TJ, DeFilippis EM, Rosenblum H, Wang EY, Redfors B, Clerkin K, Griffin JM, Wan EY, Abdalla M, Bello NA, Hahn RT, Shimbo D, Weiner SD, Kirtane AJ, Kodali SK, Burkhoff D, Rabbani LE, Schwartz A, Leon MB, Homma S, Di Tullio MR, Sayer G, Uriel N, Anstey DE.

Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection

Martínez-Del Río J, Piqueras-Flores J, Nieto-Sandoval Martín de la Sierra P, Negreira-Caamaño M, Águila-Gordo D, Mateo-Gómez C, Salas-Bravo D, Rodríguez-Martínez M.

Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis

Sanz-S√°nchez J, Vrachatis DA, Reimers B, Deftereos SG, Kallikourdis M, Vicenzi M, Giannopoulos G, Giotaki SG, Tousoulis D, Ferrante G, Condorelli G, Stefanini GG.

Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease

Nappi C, Megna R, Acampa W, Assante R, Zampella E, Gaudieri V, Mannarino T, Green R, Cantoni V, Petretta M, Cuocolo A.

Syncope, Brugada syndrome, and COVID-19 lung disease

Pasquetto G, Conti GB, Susana A, Leone LA, Bertaglia E.

Two months of radiation oncology in the heart of Italian "red zone" during COVID-19 pandemic: paving a safe path over thin ice

Buglione M, Spiazzi L, Guerini AE, Barbera F, Pasinetti N, Pegurri L, Triggiani L, Tomasini D, Greco D, Costantino G, Bragaglio A, Bonometti N, Liccioli M, Mascaro L; Radiation Oncology Department Staff, Alongi F, Magrini SM.

Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study

Masi P, Hékimian G, Lejeune M, Chommeloux J, Desnos C, Pineton De Chambrun M, Martin-Toutain I, Nieszkowska A, Lebreton G, Bréchot N, Schmidt M, Edouard Luyt C, Combes A, Frere C.

Choosing Wisely: Cardiovascular Drug Therapy in the Era of COVID-19

Nordbeck P, Hu K.

Cardiovascular comorbidities and complications associated with coronavirus disease 2019

Mahajan K, Chandra KS.

Indian Resuscitation Council (IRC) suggested guidelines for Comprehensive Cardiopulmonary Life Support (CCLS) for suspected or confirmed coronavirus disease (COVID-19) patient

Singh B, Garg R, Chakra Rao SSC, Ahmed SM, Divatia JV, Ramakrishnan TV, Mehdiratta L, Joshi M, Malhotra N, Bajwa SJS.

Thrombus in the right atrium after COVID-19 pneumonia

Alcoberro Torres L, Claver Garrido E, Moliner Borja P.

Society for Cardiovascular Magnetic Resonance (SCMR) guidance for re-activation of cardiovascular magnetic resonance practice after peak phase of the COVID-19 pandemic

Allen BD, Wong TC, Bucciarelli-Ducci C, Bryant J, Chen T, Dall'Armellina E, Finn JP, Fontana M, Francone M, Han Y, Hays AG, Jacob R, Lawton C, Manning WJ, Ordovas K, Parwani P, Plein S, Powell AJ, Raman SV, Salerno M, Carr JC.

The association between cardiac injury and outcomes in hospitalized patients with COVID-19

Karbalai Saleh S, Oraii A, Soleimani A, Hadadi A, Shajari Z, Montazeri M, Moradi H, Talebpour M, Sadat Naseri A, Balali P, Akhbari M, Ashraf H.

Veno-arterial extracorporeal membrane oxygenation may be useful in critically ill COVID-19 patients with suspected cardiac injury

Heo E, Oh SJ, Lee HW, Lee JK, Kim DK, Park SW.

CMR in the Era of COVID-19: Evaluation of Myocarditis in the Subacute Phase

Salerno M, Kwong RY.

Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus

Knowlton KU.

Cardiac involvement in a pediatric patient with COVID-19: Looking beyond the nonspecific global cardiac injury

Bhansali S, Minocha P, Phoon C, Henry G, Chakravarti S, Ramirez M, Bhatla P.

Correction to: The mystery of "missing" visits in an emergency cardiology department, in the era of COVID-19.; a time-series analysis in a tertiary Greek General Hospital

Tsioufis K, Chrysohoou C, Kariori M, Leontsinis I, Dalakouras I, Papanikolaou A, Charalambus G, Sambatakou H, Siasos G, Panagiotakos D, Tousoulis D.

Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?

Kow CS, Hasan SS.

The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection

Manolis AS, Manolis TA, Manolis AA, Melita H.

Risk and prognosis of COVID-19 in patients treated with renin-angiotensin-aldosterone inhibitors

Vistisen ST, Bodilsen J, Scheeren TWL, Simonsen U.

Cardiac Involvement in Children With COVID-19

Kohli U, Lodha R.

Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function Following Multisystem Inflammatory Syndrome in Children (MIS-C)

Jhaveri S, Ahluwalia N, Kaushik S, Trachtman R, Kowalsky S, Aydin S, Stern K.

Misinterpreting data in lipidology in the era of COVID-19

Fogacci F, Borghi C, Cicero AFG.

Commentary: Adapting the practice of congenital heart surgery to the coronavirus disease 2019 (COVID-19) pandemic

Bacha E.

Cardiac surgery in North America and coronavirus disease 2019 (COVID-19): Regional variability in burden and impact

Ad N, Luc JGY, Nguyen TC; COVID-19 North American Cardiac Surgery Survey Working Group.

Will the hidden specter of acute coronary syndrome (ACS) and ST-segment elevation myocardial infarction (STEMI) emerge from the avalanche of COVID-19?

Kapoor A, Yadav R.

Cardiological society of India document on safety measure during echo evaluation of cardiovascular disease in the time of COVID-19

Gupta R, Das MK, Mohanan PP, Deb PK, Parashar SK, Chopra HK, Shrivastava S, Guha S, Goswami KC, Yadav R, Alagesan R, Amuthan V, Bansal M, Chakraborty RN, Chakraborti N, Chandra S, Chatterjee A, Chatterjee D, Chatterjee SS, Dutta AL, De A, Garg A, Garg VK, Goyal A, Goyal NK, Govind SC, Gupta VK, Hasija PK, Jabir A, Jain P, Jain V, Jayagopal PB, Kasliwal RR, Katyal VK, Kerkar PG, Khan AK, Khanna NN, Mandal M, Majumder B, Mishra SS, Meena CB, Naik N, Narain VS, Pancholia AK, Pathak LA, Ponde CK, Ra

COVID -19 pandemic and paediatric population with special reference to congenital heart disease

Malviya A, Yadav R.

Letter to the Editors: Statins and COVID-19: Efficacy Still to Be Proven

Meunier L, Meszaros M, Pageaux GP.

Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis

Barochiner J, Martínez R.

Impact of the COVID-19 Pandemic on Interventional Cardiology Training in the United States

Shah S, Castro-Dominguez Y, Gupta T, Attaran R, Byrum K, Taleb A, Pettyjohn A, Bartel RC, Szerlip M, Henry TD, Mahmud E, Applegate RJ.

Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States

Garcia S, Stanberry L, Schmidt C, Sharkey S, Megaly M, Albaghdadi MS, Meraj PM, Garberich R, Jaffer FA, Stefanescu Schmidt AC, Dixon SR, Rade JJ, Smith T, Tannenbaum M, Chambers J, Aguirre F, Huang PP, Kumbhani DJ, Koshy T, Feldman DN, Giri J, Kaul P, Thompson C, Khalili H, Maini B, Nayak KR, Cohen MG, Bangalore S, Shah B, Henry TD.

Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19

Tedeschi D, Rizzi A, Biscaglia S, Tumscitz C.

COVID-19 in a Child with Pre-Existing Immunodeficiency, Cardiomyopathy, and Chronic Pulmonary Disease

Dinkelbach L, Franzel J, Berghäuser MA, Hoehn T, Ghosh S, Lee U, Wulf D, Schaper J, Jensen B, Niehues T, Distelmaier F, Neubert J.

The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19

Li Y, Li H, Li M, Zhang L, Xie M.

A second wave of COVID-19 infections should not lead to a new disruption of services in nuclear cardiology

Angelidis G, Valotassiou V, Psimadas D, Georgoulias P.

The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study

Dalan R, Ang LW, Tan WYT, Fong SW, Tay WC, Chan YH, Renia L, Ng LFP, Lye DC, Chew DEK, Young BE.

Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic

Gluckman TJ, Wilson MA, Chiu ST, Penny BW, Chepuri VB, Waggoner JW, Spinelli KJ.

Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19

Theocharis P, Wong J, Pushparajah K, Mathur SK, Simpson JM, Pascall E, Cleary A, Stewart K, Adhvaryu K, Savis A, Kabir SR, Uy MP, Heard H, Peacock K, Miller O.

Impact of COVID-19 on STEMI: Second youth for fibrinolysis or time to centralized approach?

Tumminello G, Barbieri L, Lucreziotti S, Gentile D, Conconi B, Centola M, Mafrici A, Carugo S.

Renin-Angiotensin-Aldosterone System Blockers Are Not Associated With Coronavirus Disease 2019 (COVID-19) Hospitalization: Study of 1,439 UK Biobank Cases

Raisi-Estabragh Z, McCracken C, Ardissino M, Bethell MS, Cooper J, Cooper C, Harvey NC, Petersen SE.

Document Addressed to Cardiovascular Echography Operators at the Time of COVID-19: A Document by the "Società Italiana di Ecocardiografia e CardioVascular Imaging" Board 2019-2021

Antonini-Canterin F, Pepi M, Monte IP, Trocino G, Barbieri A, Barchitta A, Ciampi Q, Cresti A, Miceli S, Petrella L, Benedetto F.

Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases

He F, Quan Y, Lei M, Liu R, Qin S, Zeng J, Zhao Z, Yu N, Yang L, Cao J.

[Case Report] Stress induced (Takotsubo) cardiomyopathy triggered by the COVID-19 pandemic

Giannitsi S, Tsinivizov P, Poulimenos LE, Kallistratos MS, Varvarousis D, Manolis AJ, Tsamakis K, Rizos E, Spandidos DA, Tsiptsios D, Triantafyllis AS.

"Minimalist" transcatheter aortic valve implantation during the COVID-19 pandemic: previously optional but now a necessity

Wood DA, Sathananthan J.

Possible mechanisms responsible for acute coronary events in COVID-19

Sheth AR, Grewal US, Patel HP, Thakkar S, Garikipati S, Gaddam J, Bawa D.

Cardiac Involvment in SARS-CoV-2-Associated Inflammatory Syndromes

Picichè M.

Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging

Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, Liu W, Zeng H, Tao Q, Xia L.

Cardiac Involvment in COVID-19-Related Acute Respiratory Distress Syndrome

Lazzeri C, Bonizzoli M, Batacchi S, Cianchi G, Franci A, Fulceri GE, Peris A.

Echo Training Post-COVID: Response from the National Board of Echocardiography

Labovitz AJ, Stoddard MF.

ASE Statement on the Reintroduction of Echocardiographic Services during the COVID-19 Pandemic

Hung J, Abraham TP, Cohen MS, Main ML, Mitchell C, Rigolin VH, Swaminathan M.

Right Ventricular Longitudinal Strain: A New Prognostic Tool for COVID-19?

Schiavon R, Casazza G, Cogliati C.

Relation Among Right Ventricular Dysfunction, Lung Damage, and Mortality in Patients With COVID-19

Fukui M, Cavalcante JL.

Heart(-COVID-19) Lung Interactions: More Common Cause for Right Ventricular Dysfunction Than We Thought

Tsolaki V, Zakynthinos GE.

"Quadruple Rule-Out" With Computed Tomography in a COVID-19 Patient With Equivocal Acute Coronary Syndrome Presentation

Pontone G, Baggiano A, Conte E, Teruzzi G, Cosentino N, Campodonico J, Rabbat MG, Assanelli E, Palmisano A, Esposito A, Trabattoni D.

Heart and Lung Multimodality Imaging in COVID-19

Agricola E, Beneduce A, Esposito A, Ingallina G, Palumbo D, Palmisano A, Ancona F, Baldetti L, Pagnesi M, Melisurgo G, Zangrillo A, De Cobelli F.

Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?

Pérez-Vizcaíno F.

Diabetes and COVID-19 risk: a miRNA perspective

Mishra PK, Tandon R, Byrareddy SN.

Transient Cardiomyopathy in a Patient With Coronavirus Disease-2019

Anupama BK, Thapa SS, Amzuta I.

Treatment of Aortic Aneurysms During the COVID-19 Pandemic: Time to Abandon the NICE Guidelines

McGreevy DT, Hörer TM.

Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?

Masi P, Bagate F, d'Humières T, Al-Assaad L, Abou Chakra L, Derumeaux G, Mekontso Dessap A.

COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention

Iacobazzi D, Baquedano M, Madeddu P, Caputo M.

Natural language processing for rapid response to emergent diseases: Application to calcium channel blockers therapy in hypertensive patients with COVID-19 infection

Neuraz A, Lerner I, Digan W, Paris N, Tsopra R, Rogier A, Baudoin D, Cohen KB, Burgun A, Garcelon N, Rance B.

High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia

Wiltshire E, Peña AS, MacKenzie K, Shaw G, Couper J.

Evidence-based crisis standards of care for out-of-hospital cardiac arrests in a pandemic

Natalzia P, Murk W, Thompson JJ, Dorsett M, Cushman JT, Reed P, Clemency BM; CARES Surveillance Group.

Cardiovascular Hospitalizations, Influenza Activity and COVID-19 Measures

Myhre PL, Grundvold I, Paulsen TH, Omland T, Schirmer H.

CORRIGENDUM: Editor's presentation: 'Les liaisones dangerouses. The heart in the time of COVID-19'

COVID-19-tailored approach to cardiac surgical safeguarding: stepwise protocol

Khan Y, Mallick H, Shahabuddin S.

D-dimer surge and coagulation disorders in COVID-19 related pneumonia patients with cardiac injury: A case series

Wang X, Du B, Li J, Wang S, Wang X, Guo M, Yang B, Si D, Bai O.

Lifting COVID-19 Shelter-in-Place Restrictions: Impact on Heart Failure Hospitalizations in Northeast Georgia

Ling H, Fudim M, Egolum UO.

Human Cardiac Mesenchymal Stem Cells Remodel in Disease and Can Regulate Arrhythmia Substrates

Sattayaprasert P, Vasireddi SK, Bektik E, Jeon O, Hajjiri M, Mackall JA, Moravec CS, Alsberg E, Fu J, Laurita KR.

MDM2-Mediated Ubiquitination of ACE2 Contributes to the Development of Pulmonary Arterial Hypertension

Shen H, Zhang J, Wang C, Jain PP, Xiong M, Shi X, Lei Y, Chen S, Yin Q, Thistlethwaite PA, Wang J, Gong K, Yuan ZY, Yuan JX, Shyy JY.

Immunothrombotic Dysregulation in COVID-19 Pneumonia is Associated with Respiratory Failure and Coagulopathy

Nicolai L, Leunig A, Brambs S, Kaiser R, Weinberger T, Weigand M, Muenchhoff M, Hellmuth JC, Ledderose S, Schulz H, Scherer C, Rudelius M, Zoller M, Höchter D, Keppler O, Teupser D, Zwißler B, Bergwelt-Baildon M, Kääb S, Massberg S, Pekayvaz K, Stark K.

The Impact of Coronavirus Disease 2019 (COVID-19) on First-time Acute Stroke and Transient Ischemic Attack Admission Rates and Prognosis in Denmark: A Nationwide Cohort Study

Butt JH, Fosb√∏l EL, √òstergaard L, Yafasova A, Andersson C, Schou M, Gerds TA, Phelps M, Kruuse C, Gislason GH, Torp-Pedersen C, K√∏ber L.

Right ventricular myopericarditis in COVID-19: a call for regular echocardiography

Rauch S, Regli IB, Clara A, Seraglio PME, Bock M, Poschenrieder F, Resch M.

Pneumomediastinum in COVID-19 patients: a case series of a rare complication

Volpi S, Ali JM, Suleman A, Ahmed RN.

COVID-19 pandemic: Clinical management protocols for cardiac disease patients at teaching institute in Western Rajasthan

Deora S, Bhardwaj P, Garg MK.

Coronary thrombosis in a young male with COVID-19

Shams A, Ata F, Mushtaq K, Munir W, Yousaf Z.

Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study

Yogeswaran A, Gall H, Tello K, Grünig E, Xanthouli P, Ewert R, Kamp JC, Olsson KM, Wißmüller M, Rosenkranz S, Klose H, Harbaum L, Lange TJ, Opitz CF, Waelde A, Milger K, Sommer N, Seeger W, Ghofrani HA, Richter MJ.

Torsades de Pointes in Coronavirus Disease 2019 Infection

Lalabekyan B, Kunst G, Skelton VA.

Cardiovascular Health in the COVID-19 Era: A Call for Action and Education

Vallabhajosyula S, Friedman PA, Bell MR.

Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science

Evans PC, Ed Rainger G, Mason JC, Guzik TJ, Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger J, Weber C, Bochaton-Piallat ML, Bäck M.

[At the heart of the Dutch COVID-19 epidemic: experiences of a municipal health service and a look at the future]

Westra K, Beulens CA, Sijbers-Hanegraaf MMA.

Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims

Seiffert M, Brunner FJ, Remmel M, Thomalla G, Marschall U, L'Hoest H, Acar L, Debus ES, Blankenberg S, Gerloff C, Behrendt CA.

Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19

Schwarz V, Mahfoud F, Lauder L, Reith W, Behnke S, Smola S, Rissland J, Pfuhl T, Scheller B, Böhm M, Ewen S.

Trends in acute myocardial infarction admissions during the COVID-19 pandemic in Ankara, Turkey

Kundi H, Balcı MM, Güngörer B, Yeşiltepe M, Coşkun N, Sürel AA.

Biventricular strain by speckle tracking echocardiography in COVID-19: findings and possible prognostic implications

Krishnamoorthy P, Croft LB, Ro R, Anastasius M, Zhao W, Giustino G, Argulian E, Goldman ME, Sharma SK, Kini A, Lerakis S.

Impact of COVID-19 outbreak and public lockdown on ST-elevation myocardial infarction care in Spain

Rebollal-Leal F, Aldama-López G, Flores-Ríos X, Piñón-Esteban P, Salgado-Fernández J, Calviño-Santos R, Vázquez-González N, Vázquez-Rodríguez JM.

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection

Salah HM, Calcaterra G, Mehta JL.

Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension

Saha S, Chakrabarti S, Singh PK, Poddar J, Satapathi S, Saini S, Kakar SS, Roy P.

A Systematic Review of COVID-19 and Myocarditis

Kariyanna PT, Sutarjono B, Grewal E, Singh KP, Aurora L, Smith L, Chandrakumar HP, Jayarangaiah A, Goldman SA, Salifu MO, McFarlane IM.

COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis

Ferguson K, Quail N, Kewin P, Blyth KG.

Acute Fulminant Myocarditis in a Pediatric Patient With COVID-19 Infection

Lara D, Young T, Del Toro K, Chan V, Ianiro C, Hunt K, Kleinmahon J.

Myocardial injury in COVID-19: The role of coronary computed tomography angiography (CTA)

Feuchtner GM, Barbieri F, Luger A, Skalla E, Kountchev J, Widmann G, Plank F.

The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial

Cui H, Wu F, Fan Z, Cheng X, Cheng J, Fan M.

Effects of the COVID pandemic on active non-COVID clinical trials

Gaudino M, Arvind V, Hameed I, Di Franco A, Spadaccio C, Bhatt DL, Bagiella E.

Covid-19 and the Renin Angiotensin System: Implications for the Older Adults

Bahat G.

Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey

Bennett D, De Vita E, Ventura V, Bernazzali S, Fossi A, Paladini P, Luzzi L, Maccherini M, Valente S, Bargagli E, Frediani B, Sestini P.

Asymptomatic patients with coronavirus disease and cardiac surgery: When should you operate?

Niknam J, Rong LQ.

Incorporating Health Equity and Community Perspectives During COVID-19: Commonalities with Cardiovascular Health Equity Research

Payton Foh E, Echeverria SE.

Mechanical circulatory support for cardiovascular complications in a young COVID-19 patient

Popov AF, Berger R, Schlensak C, Bongers MN, Haeberle H, Acharya M, Lausberg HF.

Lombardy regional urgent reorganization for congenital cardiac patients following the Covid-19 pandemic

Chessa M, Varrica A, Andronache A, Carminati M, Colli AM, D'Aiello AF, Ferrero P, Mannarino S, Marcora S, Marianeschi SM, Micheletti A, Piazza L, Saracino A, Uricchio N, Vignati G, Giamberti A.

Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications

Barillà F, Bassareo PP, Calcaterra G, Romeo F, Mehta JL.

Resilience and response of the congenital cardiac network in Italy during the COVID-19 pandemic

Formigari R, Marcora S, Luciani GB, Favilli S, Egidy Assenza G, Rinelli G, Meliota G, Castaldi B, Limongelli G, Flocco S, Vairo U; Italian Society of Pediatric Cardiology and Congenital Heart Disease.

Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis

Zuin M, Rigatelli G, Zuliani G, Bilato C, Zonzin P, Roncon L.

Lombardy regional urgent reorganization for congenital cardiac patients following the Covid-19 pandemic

Chessa M, Varrica A, Andronache A, Carminati M, Colli AM, D'Aiello AF, Ferrero P, Mannarino S, Marcora S, Marianeschi SM, Micheletti A, Piazza L, Saracino A, Uricchio N, Vignati G, Giamberti A.

Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients

Shah P, Owens J, Franklin J, Jani Y, Kumar A, Doshi R.

Fever Unmasking Brugada-Pattern Electrocardiogram in Patient With Coronavirus Disease 2019 (COVID-19)

Kim MS, Frenkel SL, Hayden SR.

Temporal trends in out-of-hospital cardiac arrest during the COVID-19 outbreak

Landi A, De Servi S.

Consensus on STEMI Management in the Era of COVID-19

Chopra HK, Hiremath SM, Wander GS, Kumar AS, Naik S.

Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome?

Volpe M, Battistoni A.

Severe coronary spasm in a COVID-19 patient

Rivero F, Antuña P, Cuesta J, Alfonso F.

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

Sanchis-Gomar F, Lavie CJ, Morin DP, Perez-Quilis C, Laukkanen JA, Perez MV.

Safety measures and clinical outcome of Nuclear Cardiology Department during Covid-19 lockdown pandemic: Northern Italy experience

Scrima G, D'Amico M, Bertuccio G, Canavese G, De Sanctis P.

Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19

Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T, Kario K, Kishi T, Mogi M, Nishiyama A, Ohishi M, Ohkubo T, Tamura K, Tanaka M, Yamamoto E, Yamamoto K, Itoh H.

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Hippisley-Cox J, Young D, Coupland C, Channon KM, Tan PS, Harrison DA, Rowan K, Aveyard P, Pavord ID, Watkinson PJ.

Role of Ultrasound-Guided Evaluation of Dyspnea in the Coronavirus Disease 2019 Pandemic

Neves SE, Fatima H, Walsh DP, Mahmood F, Chaudhary O, Matyal R.

Guidelines for balancing priorities in structural heart disease during the COVID-19 pandemic

Khan JM, Khalid N, Shlofmitz E, Forrestal BJ, Yerasi C, Case BC, Chezar-Azerrad C, Musallam A, Rogers T, Waksman R.

COVID-19 and cardiovascular diseases

Mai F, Del Pinto R, Ferri C.

Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2

Gilzad-Kohan H, Jamali F.

The Deadly Quartet (Covid-19, old age, lung disease, and heart failure) explain why coronavirus-related mortality in northern Italy was so high

Calcaterra G, Bassareo PP, Barilla F, Sergi D, Chiocchi M, Romeo F, Mehta JL.

Saddle pulmonary embolism and thrombus-in-transit straddling the patent foramen ovale 28 days after COVID symptom onset

Fujikura K, Fontes JD, Taub CC.

Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement

Zaman S, MacIsaac AI, Jennings GL, Schlaich MP, Inglis SC, Arnold R, Kumar S, Thomas L, Wahi S, Lo S, Naismith C, Duffy SJ, Nicholls SJ, Newcomb A, Almeida AA, Wong S, Lund M, Chew DP, Kritharides L, Chow CK, Bhindi R.

Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention

Volpe M, Battistoni A; board of the Italian Society of Cardiovascular Prevention, Bellotti P, Bellone S, Bertolotti M, Biffi A, Consoli A, Corsini A, Desideri G, Ferri C, Modena MG, Nati G, Pirro M, Rubattu S, Tocci G, Trimarco B, Volpe R, de Kreutzenberg SV.

Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon

Vlachakis PK, Tentolouris A, Kanakakis I.

Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report

Karadeniz H, Yamak BA, Özger HS, Sezenöz B, Tufan A, Emmi G.

The day after tomorrow: echocardiography laboratories after the COVID-19 outbreak

Viéitez Flórez JM, Barrios Alonso V, Fernández-Gofín C.

High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19

Song Y, Gao P, Ran T, Qian H, Guo F, Chang L, Wu W, Zhang S.

A Steep Increase in the HeartLogic Index Predicts COVID-19 Disease in an Advanced Heart Failure Patient

Heggermont W, Nguyen PAH, Lau CW, Tournoy K.

Early Left Ventricular Thrombus Formation in a COVID-19 Patient with ST-Elevation Myocardial Infarction

Sharma H, George S.

Pulling at the heart: COVID-19, race/ethnicity and ongoing disparities

Chin-Hong P, Alexander KM, Haynes N, Albert MA; Association of Black Cardiologists.

The relationship between coronary artery disease and clinical outcomes in COVID-19: a single-center retrospective analysis

Peterson E, Bryan Lo K, DeJoy R, Salacup G, Pelayo J, Bhargav R, Gul F, Albano J, Azmaiparashvili Z, Amanullah A, Patarroyo-Aponte G.

COVID-19 in patients with heart failure: the new and the old epidemic

Sisti N, Valente S, Mandoli GE, Santoro C, Sciaccaluga C, Franchi F, Cameli P, Mondillo S, Cameli M.

General practice post-COVID-19: time to put equity at the heart of health systems?

Ashwell G, Blane D, Lunan C, Matheson J.

RESPONSE: From Cardiology to COVID: The Impact of a Pandemic on Fellowship Training

Kuvin JT.

Cardiology Fellowship During the COVID-19 Pandemic: Lessons From New York City

Hadley MB, Lampert J, Zhang C.

Respiratory Variation in Central Venous Pressure (CVP) to Guide Ventilatory Support in Coronavirus Disease 2019 (COVID-19)-Related Lung Injury

La Colla L, Bronshteyn YS, Mark JB.

Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction

Hamadeh A, Aldujeli A, Briedis K, Tecson KM, Sánchez JS, Al Dujeili M, Al-Obeidi A, Luís J, Žaliūnas R, Stoler RC, McCullough PA.

Reader's CommentsAssessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic

Lotfi AS, Capatina A, Kugelmass AD.

Prognostic Value of Left Ventricular Global Longitudinal Strain in COVID-19

Janus SE, Hajjari J, Karnib M, Tashtish N, Al-Kindi SG, Hoit BD.

Heart Failure Collaboratory Statement on Remote Monitoring and Social Distancing in the Landscape of COVID-19

Abraham WT, Fiuzat M, Psotka MA, O'Connor CM.

Myocardial Injury in COVID-19 Patients: The Beginning or the End?

Uriel N, Sayer G, Clerkin KJ.

[COVID-19: a cardiological point-of-view]

Weckbach LT, Kellnar A, Stremmel C, Stark K, Kääb S.

Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19

Yenerçağ M, Arslan U, Doğduş M, Günal Ö, Öztürk ÇE, Aksan G, Erdoğan G, Gül S, Yontar OC, Şen A.

COVID-19 Infection in Children with Pre-existing Heart Disease

Simpson M, Collins C, Nash DB, Panesar LE, Oster ME.

Patient response, treatments and mortality for acute myocardial infarction during the COVID-19 pandemic

Wu J, Mamas M, Rashid M, Weston C, Hains J, Luescher T, de Belder MA, Deanfield JE, Gale CP.

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, Vehreschild M, Nagel E.

Coronavirus Disease 2019 (COVID-19) and the Heart-Is Heart Failure the Next Chapter?

Yancy CW, Fonarow GC.

Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases

Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K, Scherschel K, Kirchhof P, Escher F, Schultheiss HP, Blankenberg S, Püschel K, Westermann D.

[Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus]

Cano F, Gajardo M, Freundlich M.

Multiple spontaneous coronary thrombosis causing ST-elevation myocardial infarction in a patient with COVID-19

Kurdi H, Obaid DR, UlHaq Z, Ionescu A, Sekar B.

An international, multicentre survey of echocardiographic abnormalities in COVID-19 patients

Ng ACT, Delgado V, Bax JJ.

Prescription rates of cardiovascular and diabetes therapies prior to and during the COVID-19 lockdown in Germany‚Ä©

Kostev K, Kumar S, Konrad M, Bohlken J.

COVID-19: A Concern for Cardiovascular Disease Patients

Sharma S.

Impact of COVID-19-related public containment measures on the ST elevation myocardial infarction epidemic in Belgium: a nationwide, serial, cross-sectional study

Claeys MJ, Argacha JF, Collart P, Carlier M, Van Caenegem O, Sinnaeve PR, Desmet W, Dubois P, Stammen F, Gevaert S, Pourbaix S, Coussement P, Beauloye C, Evrard P, Brasseur O, Fierens F, Marechal P, Schelfaut D, Floré V, Hanet C.

Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19

Fox SE, Lameira FS, Rinker EB, Vander Heide RS.

Impact of public health emergency response to COVID-19 on management and outcome for NSTEMI patients in Beijing: A single-center historic control

Liu S, Song C, Yin D, Wang Y, Zhao Y, Yang W, Qiao S, Dou K, Xu B.

Cardiac manifestations of COVID-19 in Shenzhen, China

Zeng JH, Wu WB, Qu JX, Wang Y, Dong CF, Luo YF, Zhou D, Feng WX, Feng C.

Delayed isolated peri-myocarditis in a Covid-19 patient with respiratory symptoms but without lung involvement

Spano G, Fischer K, Maillat C, Vicario G, Huber AT, Gräni C.

COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management

Sattar Y, Ullah W, Rauf H, Virk HUH, Yadav S, Chowdhury M, Connerney M, Mamtani S, Pahuja M, Patel RD, Mir T, Almas T, Moussa Pacha H, Chadi Alraies M.

COVID-19 Fears May Be Worse Than the Virus: A Case of Cardiogenic Shock Secondary to Post-Myocardial Infarction Ventricular Septum Rupture

Gaballa S, AlJaf A, Patel K, Lindsay J, Hlaing KM.

Coronavirus Disease 2019 (COVID-19) Manifestation as Acute Myocardial Infarction in a Young, Healthy Male

Juthani P, Bhojwani R, Gupta N.

Considerations for Management of Acute Coronary Syndromes During the SARS-CoV-2 (COVID-19) Pandemic

Briedis K, Aldujeli A, Aldujeili M, Briede K, Zaliunas R, Hamadeh A, Stoler RC, McCullough PA.

Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review

Li X, Pan X, Li Y, An N, Xing Y, Yang F, Tian L, Sun J, Gao Y, Shang H, Xing Y.

COMMENT ON AN ARTICLE: "Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19"

Ibrahimagić OĆ, Smajlović D, Dostović Z, Vidović M, Tupković E, Kunić S.

HIIT: A potential rehabilitation treatment in COVID-19 pneumonia with heart disease

Li Y, Liu D, Wu H.

Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia

Tay EL, Hayashida K, Chen M, Yin WH, Park DW, Seth A, Kao HL, Lin MS, Ho KW, Buddhari W, Chandavimol M, Posas FE, Nguyen QN, Kong W, Rosli MA, Hon J, Firman D, Lee M.

Heart failure and COVID-19

Bader F, Manla Y, Atallah B, Starling RC.

Covid-19 and the cardiovascular system: a comprehensive review

Azevedo RB, Botelho BG, Hollanda JVG, Ferreira LVL, Junqueira de Andrade LZ, Oei SSML, Mello TS, Muxfeldt ES.

Predictive model of increased mortality and bed occupancy if thrombolysis becomes the initial treatment strategy for STEMI during the SARS-CoV-2 pandemic

Dancy L, O'Gallagher K, Ryan M, MacCarthy PA, Shah AM.

Heartbeat: Heart disease and COVID-19

Otto CM.

Extensive coronary artery thrombosis complicating COVID-19 infection and haemophagocytic lymphohistiocytosis

Dancy LH, Abu-Own H, Byrne J, Pareek N.

COVID-19 and cardiovascular comorbidities: An update

Teixeira R, Santos M, Gil V.

Heart retransplantation following COVID-19 illness in a heart transplant recipient

Soquet J, Rousse N, Moussa M, Goeminne C, Deblauwe D, Vuotto F, Pontana F, Lionet A, Dubois R, Robin E, Vincentelli A.

Sedentarism and chronic disease risk in COVID 19 lockdown - a scoping review

Chandrasekaran B, Ganesan TB.

Role of extracorporeal membrane oxygenation in COVID-19: A systematic review

Haiduc AA, Alom S, Melamed N, Harky A.

The Multiple Effects of SGLT2 Inhibitors Suggest Potential Benefit in COVID-19 Patients

Soni S, Dyck JR.

Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study

Xiong TY, Huang FY, Liu Q, Peng Y, Xu YN, Wei JF, Li N, Bai B, Li JH, Prendergast B, Li WM, Chen M.

Association between COVID-19 and cardiovascular disease

Srivastava K.

Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report

Renaud-Picard B, Gallais F, Ohana M, Zeyons F, Kretz B, Andre J, Sattler L, Hirschi S, Kessler R.

COVID-19 "Fulminant Myocarditis" Successfully Treated With Temporary Mechanical Circulatory Support

Salamanca J, Díez-Villanueva P, Martínez P, Cecconi A, González de Marcos B, Reyes G, Salas C, Segovia J, Jiménez-Borreguero LJ, Alfonso F.

Cardiovascular complications in COVID-19

Butt N, Arshid A, Ahmad SA, Khalid N, Kayani WT.

The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19

Selvaraj S, Greene SJ, Ahmed M Khatana S, Nathan AS, Solomon SD, Bhatt DL.

Cardio-Oncology in Era of the COVID-19 Pandemic and Beyond

Addison D, Campbell CM, Guha A, Ghosh AK, Dent SF, Jneid H.

The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients

Du H, Wang DW, Chen C.

The Basics of ARDS Mechanical Ventilatory Care for Cardiovascular Specialists

Rayner-Hartley E, Miller PE, Burstein B, Bibas L, Goldfarb M, Rampersad P, van Diepen S.

The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future

Zhang J, Wang M, Ding W, Wan J.

Delineating clinical characteristics and comorbidities among 206 COVID-19deceasedpatients in India: Emerging significance of renin angiotensin system derangement

Majeed J, Ajmera P, Goyal RK.

Multimodality Imaging in Evaluation of Cardiovascular complications in Patients with COVID-19

Rudski L, Januzzi JL, Rigolin VH, Bohula EA, Blankstein R, Patel AR, Bucciarelli-Ducci C, Vorovich E, Mukherjee M, Rao SV, Beanlands R, Villines TC, Di Carli MF.

A 65-Year-Old Woman with a History of Type 2 Diabetes Mellitus and Hypertension and a 15-Day History of Dry Cough and Fever Who Presented with Acute Renal Failure Due to Infection with SARS-Cov-2

Sánchez Tinajero Á, González Cueto E, Martínez Orozco JA, Becerril Vargas E, Ruiz Santillán DP, Reséndiz Escobar H.

Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain

Vila-Corcoles A, Satue-Gracia E, Ochoa-Gondar O, Torrente-Fraga C, Gomez-Bertomeu F, Vila-Rovira A, Hospital-Guardiola I, de Diego-Cabanes C, Bejarano-Romero F, Rovira-Veciana D, Basora-Gallisa J.

Is it all in the heart? Myocardial injury as major predictor of mortality among hospitalized COVID-19 patients

Harmouch F, Shah K, Hippen J, Kumar A, Goel H.

Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019

Siri-Angkul N, Chattipakorn SC, Chattipakorn N.

Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI : Endorsed by the Infectious Diseases Society of America

Skali H, Murthy VL, Paez D, Choi EM, Keng FYJ, Iain MA, Al-Mallah M, Campisi R, Bateman TM, Carrio I, Beanlands R, Calnon DA, Dilsizian V, Dondi M, Gimelli A, Pagnanelli R, Polk DM, Soman P, Einstein AJ, Dorbala S, Thompson RC.

COVID-19: frequently asked questions to the cardiologist

Kammerlander AA, Mascherbauer J.

A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy

Iacovoni A, Boffini M, Pidello S, Simonato E, Barbero C, Sebastiani R, Vittori C, Fontana A, Terzi A, De Ferrari GM, Rinaldi M.

The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients

Zamai L.

Cardiac Surgeons against the COVID-19 Pandemic

Guerra M.

Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?

Smeda M, Chlopicki S.

A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19

Martinelli N, Montagnana M, Pizzolo F, Friso S, Salvagno GL, Forni GL, Gianesin B, Morandi M, Lunardi C, Lippi G, Polati E, Olivieri O, De Franceschi L.

Outcomes of In-Hospital Cardiac Arrest in Patients with COVID-19 in New York City

Sheth V, Chishti I, Rothman A, Redlener M, Liang J, Pan D, Mathew J.

COVID-19-Related Cardiovascular Disease and Practical Considerations for Perioperative Clinicians

Gerstein NS, Venkataramani R, Goumas AM, Chapman NN, Deriy L.

High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19

Setia G, Tyler J, Kwan A, Faguet J, Sharma S, Singh S, Azarbal B, Tompkins R, Chinchilla D, Ghandehari S.

Safe performance of echocardiography during the COVID-19 pandemic: a practical guide

Cameli M, Pastore MC, Henein M, Aboumarie HS, Mandoli GE, D'Ascenzi F, Cameli P, Franchi F, Mondillo S, Valente S.

SARS-CoV-2 post-infective myocarditis: the tip of COVID-19 immune complications?

Tissières P, Teboul JL.

Unveiling the mystery of "missing" emergencies in the era of COVID-19 pandemic: a generalized phenomenon with unclarified implications

Tsioufis K, Chrysohoou C, Leontsinis I, Tousoulis D.

Apical Takotsubo Cardiomyopathy in a COVID-19 Patient Presenting with Stroke: A Case Report and Pathophysiologic Insights

Kariyanna PT, Chandrakumar HP, Jayarangaiah A, Khan A, Vulkanov V, Ashamalla M, Salifu MO, McFarlane SI.

Cardiopulmonary Physical Therapist; A rescuer for the patients suffering from COVID-19

Awan MMA, Qureshi S, Khushnood K.

Multilead QT Screening Is Necessary for QT Measurement: Implications for Management of Patients in the COVID-19 Era

Cheung CC, Davies B, Gibbs K, Laksman ZW, Krahn AD.

Is Increased Sleep Responsible for Reductions in Myocardial Infarction During the COVID-19 Pandemic?

Advani I, Gunge D, Banks S, Mehta S, Park K, Patel M, Malhotra A, Crotty Alexander LE.

Cardiology Practice and Training Post-COVID-19: Achieving "Normalcy" After Disruption

Narula N, Singh HS.

IL-6 Blockade and QTc Prolongation in COVID-19

Lazzerini PE, Laghi-Pasini F, Acampa M, Boutjdir M, Capecchi PL.

Prognostic value of Cardiac Biomarkers in COVID-19 Infection: A Meta-analysis

Dawson D, Dominic P, Sheth A, Modi M.

Cardiac tamponade as a cause of cardiac arrest in severe COVID-19 pneumonia

Ruiz-Rodríguez JC, Camón LC, Ruiz D, Lacasa JS, Serra EA, Casals FXN, Ferrer R.

Continued in-hospital ACE inhibitor and ARB Use in hypertensive COVID-19 patients is associated with positive clinical outcomes

Lam KW, Chow KW, Vo J, Hou W, Li H, Richman PS, Mallipattu SK, Skopicki HA, Singer AJ, Duong TQ.

The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study

Mangion K, Morrow A, Bagot C, Bayes H, Blyth KG, Church C, Corcoran D, Delles C, Gillespie L, Grieve D, Ho A, Kean S, Lang NN, Lennie V, Lowe D, Kellman P, Macfarlane PW, McConnachie A, Roditi G, Sykes R, Touyz RM, Sattar N, Wereski R, Wright S, Berry C.

Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients

Kow CS, Thiruchelvam K, Hasan SS.

Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results from a Multicenter Survey

Samsky MD, DeVore AD, McIlvennan CK, Granger CB, Granger BB, Hernandez AF, Felker GM, Fonarow GC, Albert NM, Piña IL, Lanfear D, Allen LA.

Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?

Inciardi RM, Adamo M, Lupi L, Metra M.

ST Elevation in a Patient With COVID-19 Infection-Associated Fever: A Case of Brugada Pattern

Mahadevaiah G, Aleem A, Secaira A, Saba S, Shariff N.

A 73-Year-Old Man with a History of Hypertension and Ischemic Heart Disease Who Presented with Pain in the Right Flank as a Symptom of COVID-19 Pneumonia

Veliyankodan Parambil J, Abdulrahman R, Al-Shokri S.

Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) Pandemic

DeFilippis EM, Sinnenberg L, Reza N, Givertz MM, Kittleson MM, Topkara VK, Farr MA.

COVID-19 and hypertensive disease in Brazil: possibility of a perfect storm

Melo DO, Ribeiro TB, Grezzana GB, Stein AT.

The detrimental effect of COVID-19 nationwide quarantine on accelerometer-assessed physical activity of heart failure patients

Vetrovsky T, Frybova T, Gant I, Semerad M, Cimler R, Bunc V, Siranec M, Miklikova M, Vesely J, Griva M, Precek J, Pelouch R, Parenica J, Belohlavek J.

COVID-19 and cardiovascular disease

Nicholls M.

Management of Immunosuppression During Severe COVID-19 Infection in a Patient With Pulmonary and Cardiac Sarcoidosis

Padala SA, Medepalli VM, Mohammed A, Vakiti A, Elam R, Gupta SJ.

Cardiac magnetic resonance characterization of COVID-19 myocarditis

Caballeros Lam M, de la Fuente Villena A, Hernández Hernández A, García de Yébenes M, Bastarrika Alemañ G.

Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

Vivas D, Roldán V, Esteve-Pastor MA, Roldán I, Tello-Montoliu A, Ruiz-Nodar JM, Cosín-Sales J, Gámez JM, Consuegra L, Ferreiro JL, Marín F; Expert reviewers.

Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: A case report and literature review

Khatri A, Wallach F.

Increased mortality among hypertensive COVID-19 patients: Pay a closer look on diuretics in mechanically ventilated patients

Tsolaki V, Zakynthinos GE, Mantzarlis K, Makris D.

HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic

Varma N, Marrouche NF, Aguinaga L, Albert CM, Arbelo E, Choi JI, Chung MK, Conte G, Dagher L, Epstein LM, Ghanbari H, Han JK, Heidbuchel H, Huang H, Lakkireddy DR, Ngarmukos T, Russo AM, Saad EB, Saenz Morales LC, Sandau KE, Sridhar ARM, Stecker EC, Varosy PD.

"Missing" acute coronary syndrome hospitalizations during the COVID-19 era in Greece: Medical care avoidance combined with a true reduction in incidence?

Papafaklis MI, Katsouras CS, Tsigkas G, Toutouzas K, Davlouros P, Hahalis GN, Kousta MS, Styliadis IG, Triantafyllou K, Pappas L, Tsiourantani F, Varytimiadi E, Anyfantakis ZA, Iakovis N, Grammata P, Karvounis H, Ziakas A, Sianos G, Tziakas D, Pappa E, Dagre A, Patsilinakos S, Trikas A, Lamprou T, Mamarelis I, Katsimagklis G, Karmpaliotis D, Naka K, Michalis LK.

Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned

Sultan S, Acharya Y.

Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19

Gue YX, Gorog DA.

ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19

Lupi L, Adamo M, Inciardi RM, Metra M.

COVID-19 and Myocarditis: What Do We Know So Far?

Pirzada A, Mokhtar AT, Moeller AD.

COVID-19 Pandemic: Global Impact and Potential Implications for Cardiovascular Disease in Canada

Botly LCP, Martin-Rhee M, Kasiban A, Swartz RH, Mulvagh SL, Lindsay MP, Goia C, Smith EE, Hill MD, Field TS, Krahn AD, Oudit GY, Zieroth S, Yip CYY.

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC.

Cardiopulmonary resuscitation in primary and community care during the COVID-19 pandemic

Khunti K, Straube S, Adisesh A, Chan XHS, Banerjee A, Greenhalgh T.

Unexpected Features of Cardiac Pathology in COVID-19 Infection

Fox SE, Li G, Akmatbekov A, Harbert JL, Lameira FS, Brown JQ, Vander Heide RS.

Adult cardiac surgery during the COVID-19 pandemic: A tiered patient triage guidance statement

Haft JW, Atluri P, Ailawadi G, Engelman DT, Grant MC, Hassan A, Legare JF, Whitman GJR, Arora RC; Society of Thoracic Surgeons COVID-19 Task Force and the Workforce for Adult Cardiac and Vascular Surgery.

Adult cardiac surgery and the COVID-19 pandemic: Aggressive infection mitigation strategies are necessary in the operating room and surgical recovery

Engelman DT, Lother S, George I, Funk DJ, Ailawadi G, Atluri P, Grant MC, Haft JW, Hassan A, Legare JF, Whitman GJR, Arora RC; Society of Thoracic Surgeons COVID-19 Task Force.

Systemic inflammation with cardiac involvement in pediatric patients with evidence of COVID-19 in a community hospital in the Bronx, NY

Rogo T, Mathur K, Purswani M.

COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease

Kadosh BS, Garshick MS, Gaztanaga J, Moore KJ, Newman JD, Pillinger M, Ramasamy R, Reynolds HR, Shah B, Hochman J, Fishman GI, Katz SD.

Influence of inhibitors of the renin-angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients

Holt A, Mizrak I, Lamberts M, Lav Madsen P.

Cardiac emergencies during the COVID-19 pandemic in the light of the current evidence

Sokolski M, Sokolska JM, Zymliński R, Biegus J, Banasiak W, Reczuch K, Ponikowski P.

Chloroquine and hydroxychloroquine for the prevention and therapy of COVID-19: new hopes and old cardiovascular concerns

Jankowska EA, Sierpiński R, Tkaczyszyn M, Drozd M, Szachniewicz J, Duda-Sikuła M, Knysz B, Simon K, Szenborn L, Ponikowski P.

Efficacy of ACEIs/ARBs versus CCBs on the progression of COVID-19 patients with hypertension in Wuhan: A hospital-based retrospective cohort study

Liu X, Liu Y, Chen K, Yan S, Bai X, Li J, Liu D.

A brief guidance for cardiologists for resource containment measures to mitigate anticipated shortages of n-95 filtering facepiece respirators during COVID-19 pandemic

Kapoor P, Kapoor A, Azim A.

Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions

Siudak Z, Grygier M, Wojakowski W, Malinowski KP, Witkowski A, GƒÖsior M, Dudek D, Bartu≈õ S.

[An unusual presentation of cardiac involvement during the COVID-19 pandemic]

Pecora D, La Greca C, Pezzotti E, Botti P, Campana M, Cuccia C.

[Cardiac surgery and COVID-19 outbreak: operative indications for the phase 2 by the COVID-SICCH Task Force]

Di Mauro M, Barili F, Bonalumi G, Garatti A, Parolari A, Gerosa G.

[ANMCO Position paper: Cardiological outpatient activities in the transition phase of the COVID-19 pandemic]

Valente S, Colivicchi F, Francese MG, Di Lenarda A, Roncon L, Murrone A, Caldarola P, Bilato C, Amodeo E, Aspromonte N, Cipriani M, Domenicucci S, Imazio M, Scotto di Uccio F, Urbinati S, Gulizia MM, Gabrielli D.

[ANMCO Position paper: Pulmonary circulation diseases and COVID-19]

Picariello C, Caravita S, Vatrano M, Enea I, Roncon L, De Tommasi E, Imbalzano E, Garascia A, Manes MT, Misuraca L, Urbinati S, Colivicchi F, Gulizia MM, Gabrielli D; a nome dell’Area Malattie del Circolo Polmonare ANMCO.

[COVID-19: a gendered disease? Possible interpretations and knowledge limitations]

Lodi E, Scavone A, Reggianini L, Modena MG.

[Being cardiologist at the time of SARS-CoV-2: what do not forget during the post-pandemic phase?]

Tarantini L, Faggiano P, Navazio A, Turiano G, Colivicchi F, Gabrielli D.

Cardiac surgeons between apprehension and ethical duty in the COVID-19 pandemic

Bakry AM, Sobhy E, Abdelmohty H.

COVID-19 Presenting as Takotsubo Cardiomyopathy Complicated with Atrial Fibrillation

Sattar Y, Connerney M, Ullah W, Philippou A, Slack D, McCarthy B, Kroll S, Luddington S, Ruiz Maya T, Alraies MC.

Spectrum of Cardiac Involvement in COVID-19

Gill GS, Vlacancich R, Mehta N, Chaturvedi M, Papolos A.

A Case Report of Polymerase Chain Reaction-Confirmed COVID-19 in a Patient With Right Ventricular Thrombus and Bilateral Deep Vein Thrombosis

Elkattawy S, Younes I, Noori MAM.

Telecardiology during the Covid-19 pandemic: past mistakes and future hopes

De Simone V, Guarise P, Guardalben S, Padovani N, Tondelli S, Sandrini D, Visentin E, Zanotto G.

Acute cardiac injury in patients with COVID-19

De Lorenzo A, Kasal DA, Tura BR, Lamas CC, Rey HC.

Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade

Chenna A, Konala VM, Bose S, Roy S, Madhira BR, Gayam V, Naramala S, Adapa S.

Brugada syndrome

Korlipara H, Korlipara G, Pentyala S.

Pathogenesis and Management of Myocardial Injury in Coronavirus Disease 2019

Wei ZY, Qian HY, Huang J, Geng YJ.

Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)

Subir R, Jagat J M, Kalyan K G.

Reduced rate of hospital presentations for heart failure during the Covid-19 pandemic in Toronto, Canada

Frankfurter C, Buchan TA, Kobulnik J, Lee DS, Luk A, McDonald M, Ross HJ, Alba AC.

Suboptimal Rates of Return of Spontaneous Circulation with Prehospital CPR in the COVID-19 Era

Shekhar AC, Mercer C, Blumen I, Narula J.

Are statins safe in patients with COVID-19?

Karalis DG.

Aerosol-Containment Device for Prevention of Aerosol Dispersion During Nebulization in COVID-19 Patients

Kumar A, Kumar A, Sinha C, Kumar N, Kumar A.

Management of acute coronary syndrome in patients with suspected or confirmed coronavirus disease 2019: Consensus from Taiwan Society of Cardiology

Li YH, Wang MT, Huang WC, Hwang JJ.

The cardiothoracic surgery trainee experience during the coronavirus disease 2019 (COVID-19) pandemic: Global insights and opportunities for ongoing engagement

Olive JK, Luc JGY, Cerqueira RJ, Eulert-Grehn JJ, Han JJ, Phan K, Preventza O.

The cardiac intensive care unit and the cardiac intensivist during the COVID-19 surge in New York City

Anstey DE, Givens R, Clerkin K, Fried J, Kalcheva N, Kumaraiah D, Masoumi A, O'Connor D, Rosner GF, Wasson L, Hammond J, Kirtane AJ, Uriel N, Schwartz A, Rabbani LE, Abdalla M.

SARS-CoV-2 and the cardiovascular system

Hafiane A.

The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19

Deng P, Ke Z, Ying B, Qiao B, Yuan L.

Coagulopathy in COVID-19: Focus on vascular thrombotic events

Shi W, Lv J, Lin L.

SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production

Franco R, Rivas-Santisteban R, Serrano-Marín J, Rodríguez-Pérez AI, Labandeira-García JL, Navarro G.

[Persistent chest pain after resolution of coronavirus 2019 disease (COVID-19)]

Tung-Chen Y, Blanco-Alonso S, Antón-Huguet B, Figueras-López C, Ugueto-Rodrigo C.

Cardiac rehabilitation programs for heart failure patients in the time of COVID-19

Schmidt C, Magalh√£es S, Barreira A, Ribeiro F, Fernandes P, Santos M.

Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?

Vitiello A, Ferrara F.

The impact of COVID-19 pandemic on adult cardiac surgery procedures

Lazaros G, Oikonomou E, Theofilis P, Theodoropoulou A, Triantafyllou K, Charitos C, Charalambous G, Papanikolaou A, Gastouniotis I, Siasos G, Vlachopoulos C, Tousoulis D.

High Thrombus Burden in Patients with COVID-19 Presenting with ST-Elevation Myocardial Infarction

Choudry FA, Hamshere SM, Rathod KS, Akhtar MM, Archbold RA, Guttmann OP, Woldman S, Jain AK, Knight CJ, Baumbach A, Mathur A, Jones DA.

Out-of-hospital Cardiac Arrest and Acute Coronary Syndrome Hospitalizations during the COVID-19 Surge

Mountantonakis SE, Saleh M, Coleman K, Kuvin J, Singh V, Jauhar R, Ong L, Qiu M, Epstein LM.

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

Mafham MM, Spata E, Goldacre R, Gair D, Curnow P, Bray M, Hollings S, Roebuck C, Gale CP, Mamas MA, Deanfield JE, de Belder MA, Luescher TF, Denwood T, Landray MJ, Emberson JR, Collins R, Morris EJA, Casadei B, Baigent C.

Extracorporeal membrane oxygenation and COVID-19: The causes of failure

Ahmadi ZH, Jahangirifard A, Farzanegan B, Tabarsi P, Abtahian Z, Abedini A, Sharifi M, Jadbabaei AN, Mafhumi Y, Moslem A, Sistani M, Yousefian S, Saffaei A, Dastan F.

TEVAR for a Marfan patient during COVID-19 pandemic

Ikeda S, Shih M, Rhee RY, Youdelman BA.

COVID-19: how things change in a while

Stolfo D, Sinagra G.

Innovation in transforming a large-scale scientific medical conference in China entirely online in response to COVID-19

Li J, Li Y, Huo Y.

COVID-19 pandemic: a sentiment analysis

Kumar A, Khan SU, Kalra A.

Pulmonary Vascular Pathology in Covid-19. Reply

Ackermann M, Mentzer SJ, Jonigk D.

Pulmonary Vascular Pathology in Covid-19

Scholkmann F, Nicholls J.

Pulmonary Vascular Pathology in Covid-19

Som A, Lang M, Little B.

Pulmonary Vascular Pathology in Covid-19

Burel-Vandenbos F, Cardot-Leccia N, Passeron T.

Cardiovascular diseases, lipid-lowering therapies and European registries in the COVID-19 pandemic

Morawietz H, Julius U, Bornstein SR.

Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm

Masoudi-Sobhanzadeh Y, Masoudi-Nejad A.

Microthrombi and ST-Segment Elevation Myocardial Infarction in COVID-19

Guagliumi G, Sonzogni A, Pescetelli I, Pellegrini D, Finn AV.

Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease

Inciardi RM, Solomon SD, Ridker PM, Metra M.

The cardiovascular effects of treatment with hydroxychloroquine and azithromycin

Simmering JE, Polgreen LA, Polgreen PM, Teske RE, Comellas AP, Carter BL.

The Netherlands Heart Journal: special issue on COVID-19

Vendrik J, Piek JJ.

Recommendations on how to provide cardiac rehabilitation services during the COVID-19 pandemic

Kemps HMC, Brouwers RWM, Cramer MJ, Jorstad HT, de Kluiver EP, Kraaijenhagen RA, Kuijpers PMJC, van der Linde MR, de Melker E, Rodrigo SF, Spee RF, Sunamura M, Vromen T, Wittekoek ME; Committee for Cardiovascular Prevention and Cardiac Rehabilitation of the Netherlands Society of Cardiology.

How cardiologists respond to COVID-19: the experience of West China Hospital, China

Ma M, Yang ZG, He Y.

Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection

Moschini L, Loffi M, Regazzoni V, Di Tano G, Gherbesi E, Danzi GB.

Impact of COVID-19 outbreak on regional STEMI care in Germany

Scholz KH, Lengenfelder B, Thilo C, Jeron A, Stefanow S, Janssens U, Bauersachs J, Schulze PC, Winter KD, Schröder J, Vom Dahl J, von Beckerath N, Seidl K, Friede T, Meyer T.

Multisystem manifestations of COVID-19 in a patient presenting to a heart attack centre

Malaweera A, Papachristidis A, Harding I, Pareek N.

Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study

Dublin S, Walker RL, Floyd JS, Shortreed SM, Fuller S, Albertson-Junkans LH, Harrington LB, Greenwood-Hickman MA, Green BB, Psaty BM.

The Crucial Importance of Optimal Primary and Secondary Prevention of Cardiovascular Disease during COVID-19 Pandemic

Akşit E, Gazi E, Kırılmaz B, Yıldırım ÖT, Aydın F.

Managing Pulmonary Hypertension in Times of COVID-19

Wang YC, Huang WC, Cheng CC, Hung CC, Kuo FY, Mar GY.

Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19

Pagnesi M, Baldetti L, Beneduce A, Calvo F, Gramegna M, Pazzanese V, Ingallina G, Napolano A, Finazzi R, Ruggeri A, Ajello S, Melisurgo G, Camici PG, Scarpellini P, Tresoldi M, Landoni G, Ciceri F, Scandroglio AM, Agricola E, Cappelletti AM.

Prime time for handheld echocardiography in COVID-19 pandemic

Jenkins S, Garg P.

Lessons of the month 3: ST-elevation myocardial infarction and left ventricular thrombus formation: an arterial thrombotic complication of severe COVID-19 infection

Fenton M, Siddavaram S, Sugihara C, Husain S.

The cardiovascular burden of congenital heart disease - not only in times of COVID-19

Müller J, Brudy L, Meyer M, Ewert P, Oberhoffer R.

The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents

De Spiegeleer A, Bronselaer A, Teo JT, Byttebier G, De Tré G, Belmans L, Dobson R, Wynendaele E, Van De Wiele C, Vandaele F, Van Dijck D, Bean D, Fedson D, De Spiegeleer B.

Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?

Bloch MJ.

Vascular risk factors, Framingham risk score, and COVID-19: community-based cohort study

Batty GD, Hamer M.

The prevalence of cardiovascular comorbidities in COVID-19, SARS and MERS: pooled analysis of published data

Liu Y, Wu S, Qin M, Jiang W, Liu X.

Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19

Wu C, Ye D, Mullick AE, Li Z, Danser AHJ, Daugherty A, Lu HS.

COVID-19: Myocardial injury in survivors

Knight DS, Kotecha T, Razvi Y, Chacko L, Brown JT, Jeetley PS, Goldring J, Jacobs M, Lamb LE, Negus R, Wolff A, Moon JC, Xue H, Kellman P, Patel N, Fontana M.

Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19

Qin JJ, Cheng X, Zhou F, Lei F, Akolkar G, Cai J, Zhang XJ, Blet A, Xie J, Zhang P, Liu YM, Huang Z, Zhao LP, Lin L, Xia M, Chen MM, Song X, Bai L, Chen Z, Zhang X, Xiang D, Chen J, Xu Q, Ma XL, Touyz RM, Gao C, Wang H, Liu L, Mao W, Luo P, Yan Y, Ye P, Chen M, Chen G, Zhu L, She ZG, Huang X, Yuan Y, Zhang BH, Wang Y, Liu PP, Li H.

COVID-19-Associated Stress (Takotsubo) Cardiomyopathy

Tsao CW, Strom JB, Chang JD, Manning WJ.

Epidemiology, prognosis and clinical manifestation of cardiovascular disease in COVID-19

Capone V, Cuomo V, Esposito R, Canonico ME, Ilardi F, Prastaro M, Esposito G, Santoro C.

COVID-19 complicated by ST-segment elevation myocardial infarction in a 29-year-old patient

Ong E, Castro-Dominguez Y, Brennan J, Oen-Hsiao J.

Cardiac rehabilitation and telemedicine (and COVID-19)

Peters RJG.

SARS-CoV-2/COVID-19: a primer for cardiologists

de Vries AAF.

Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective

Talasaz AH, Kakavand H, Van Tassell B, Aghakouchakzadeh M, Sadeghipour P, Dunn S, Geraiely B.

Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis

Greco A, Buccheri S, D'Arrigo P, Calderone D, Agnello F, Monte M, Milluzzo RP, Franchina AG, Ingala S, Capodanno D.

Subclinical coronary artery disease in COVID-19 patients

Nai Fovino L, Cademartiri F, Tarantini G.

Disrupting the Electrical Circuit: New Onset Atrial Fibrillation in a Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Radwan S, Schwartz O.

SARS-CoV-2 (COVID 19) Infection in Hypertensive Patients and in Patients With Cardiac Disease

Cancarevic I, Malik BH.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Induced Cardiovascular Syndrome: Etiology, Outcomes, and Management

Turshudzhyan A.

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart

D'Elia E, Senni M.

Cardiovascular Implications of COVID-19 Infections

Thakkar AN, Tea I, Al-Mallah MH.

Covid-19: Data show 5000 fewer hospital admissions for acute coronary syndrome during pandemic

Griffin S.

Consensus statement on coronary intervention during the coronavirus disease 19 pandemic: from the Korean Society of Interventional Cardiology

Lee KY, Lee BK, Kim WJ, Kang SH, Park TK, Kim SY, Suh JW, Yoon CH, Yang DH, Ryu SK, Kim SH, Lee SY, Chae IH; Korean Society of Interventional Cardiology COVID-19 Task Force Team.

Prioritizing cardiovascular surgical care in COVID-19 pandemic: Shall we operate or defer?

Patel S, Kaushik A, Sharma AK.

COVID-19 patient bridged to recovery with veno-venous extracorporeal membrane oxygenation

Rinewalt D, Coppolino A, Seethala R, Sharma N, Salim A, Keller S, Mallidi HR.

Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID-19 infection

Popovic B, Varlot J, Metzdorf PA, Jeulin H, Goehringer F, Camenzind E.

Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?-Reply

Fan Y, Guo T, Lu Z.

Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?

Giannopoulos G, Vrachatis DA, Deftereos SG.

Cardiac surgery in the time of the novel coronavirus: Why we should think to a new normal

Tamagnini G, Biondi R, Ricciardi G, Rutigliano R, Trias-Llimós S, Meuris B, Lamelas J, Del Giglio M.

Surgical management of thoracic aortic emergency with pre- and postoperative COVID-19 disease

Mori M, Geirsson A, Vallabhajosyula P, Assi R.

TEVAR in aortic dissection: A new standard for Marfan patients during COVID-19?

Harky A, Abdelmalak R, Torella F, Field M.

Cardiothoracic surgery during the Covid-19 pandemic: Perioperative care, safety, and surgical results

Casanova J, Pissarra D, Costa R, Salgueiro E, Pinho P.

Association between cardiovascular manifestation and COVID-19

Miki K, Imamura T.

Cardiovascular manifestations in severe and critical patients with COVID-19

Chen Q, Xu L, Zhu W, Ge J.

Perioperative management of COVID-19 patients undergoing cardiac surgery with cardiopulmonary bypass

Gunaydin S, Stammers AH.

Noteworthy Electrocardiographic Changes Following Pharmacologic Treatment of COVID-19

Kozik TM, Mitchell M, Al-Zaiti SS, Carey MG, Pelter MM.

ST-elevation acute myocardial infarction during COVID-19 pandemic: Are we missing the boat?

Buono A, Ammirati E.

The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19

Bosso M, Thanaraj TA, Abu-Farha M, Alanbaei M, Abubaker J, Al-Mulla F.

Transient Type 1 Brugada Pattern without Ongoing Fever during COVID-19 Pneumonia

Pasqualetto MC, Corrado A, Secco E, Graceffa F, Rigo F.

Unusually Rapid Development of Pulmonary Hypertension and Right Ventricular Failure after COVID-19 Pneumonia

van Dongen CM, Janssen MT, van der Horst RP, van Kraaij DJ, Peeters RH, van den Toorn LM, Mostard RL.

Acute life-threatening cardiac tamponade in a mechanically ventilated patient with COVID-19 pneumonia

Derveni V, Kaniaris E, Toumpanakis D, Potamianou E, Ioannidou I, Theodoulou D, Kyriakoudi A, Kyriakopoulou M, Pontikis K, Daganou M.

Interruption of the European Association of Cardiothoracic Anaesthesiology (EACTA) Fellowship Program During the Coronavirus Disease 2019 Pandemic: Consequences and Solutions

El-Tahan MR, Schreiber JU, Diprose P, Wilkinson K, Guarracino F, Erdoes G.

Cardiac Catheterization Laboratory Volume Changes During COVID-19-Findings from a Cardiovascular Fellows Consortium

Kadavath S, Mohan J, Ashraf S, Kassier A, Hawwass D, Madan N, Salehi N, Bernardo M, Mawri S, Rehman KA, Ya'qoub L, Strobel A, Dixon SR, Siraj A, Messenger J, Spears JR, Lopez-Candales A, Madder R, Bailey SR, Alaswad K, Kim MC, Safian RD, Alraies MC.

Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study

Rodriguez-Nava G, Trelles-Garcia DP, Yanez-Bello MA, Chung CW, Trelles-Garcia VP, Friedman HJ.

Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial Infarction

Reinstadler SJ, Reindl M, Lechner I, Holzknecht M, Tiller C, Roithinger FX, Frick M, Hoppe UC, Jirak P, Berger R, Delle-Karth G, Laßnig E, Klug G, Bauer A, Binder R, Metzler B.

Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review

Zaki N, Alashwal H, Ibrahim S.

Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia

Liu Q, Chen H, Zeng Q.

Management of crash and burn patients with SARS-CoV-2 associated ARDS

Ghodsizad A, Grant AA, Mirsaeidi M, Sneij WC, Khalid L, Delazerda D, Auerbach JS, Alvarez RA, de Marchena EJ, Hare J, Guerra G, Vianna R, Loebe M.

Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series

Bona RD, Valbusa A, Malfa G, Giacobbe DR, Ameri P, Patroniti N, Robba C, Gilad V, Insorsi A, Bassetti M, Pelosi P, Porto I; GECOVID study group.

Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis

Tschöpe C, Van Linthout S, Jäger S, Arndt R, Trippel T, Müller I, Elsanhoury A, Rutschow S, Anker SD, Schultheiss HP, Pauschinger M, Spillmann F, Pappritz K.

COVID-19: FAQs-Congenital Heart Surgery Recovery and Defining a "New Normal"

Dearani JA, Stephens EH, Guleserian KJ, Overman DM, Backer CL, Romano JC, St Louis JD, Sarris GE, Bacha E, Tweddell JS.

Return to sports after COVID-19: a position paper from the Dutch Sports Cardiology Section of the Netherlands Society of Cardiology

Verwoert GC, de Vries ST, Bijsterveld N, Willems AR, Vd Borgh R, Jongman JK, Kemps HMC, Snoek JA, Rienks R, Jorstad HT.

Ongoing transcatheter aortic valve implantation (TAVI) practice amidst a global COVID-19 crisis: nurse-led analgesia for transfemoral TAVI

Vendrik J, de Boer J, Zwiers W, van Gilst SA, Holierook M, Chekanova EV, Henriques JS, Baan J Jr.

Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool

Momtazmanesh S, Shobeiri P, Hanaei S, Mahmoud-Elsayed H, Dalvi B, Malakan Rad E.

Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna's Autonomic Unit

Guaraldi P, Barletta G, Baschieri F, Calandra-Buonaura G, Provini F, Cortelli P.

Identifying very low-risk STEMI patients for early ICU discharge in the COVID-19 era

Altisent OA, Carrillo X, Puri R, Bayés-Genís A.

Anesthetic Considerations During Heart Transplantation Using Donation After Circulatory Death

Ngai J, Masuno K, Moazami N.

Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19

Seelhammer TG, Rowse P, Yalamuri S.

Adults with congenital heart disease during the coronavirus disease 2019 (COVID-19) pandemic: are they at risk?

Gallego P, Ruperti-Repilado FJ, Schwerzmann M.

COVID-19, Renin-Angiotensin System and Endothelial Dysfunction

Amraei R, Rahimi N.

[Cardiac adverse effects of hydroxychloroquine and the need for tests]

Zaidel EJ, Wyss Quintana FS, Sosa Liprandi Á, Mendoza I, Márquez MF, Nuñez E, Barbosa M, Baranchuk A.

[Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic]

Bozzo R, Ibelli F, Scublinsky D.

Correction to: Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome

Correction to: Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak

COVID-19 Leads to Major Changes for Cardiologists in Training

Kuehn BM.

Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm

Spyropoulos AC, Weitz JI.

Impact on hospital admission of ST-elevation myocardial infarction patients during coronavirus disease 2019 pandemic in an Italian Hospital

Di Liberto IA, Pilato G, Geraci S, Milazzo D, Vaccaro G, Buccheri S, Caramanno G.

Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality

Imazio M, Brucato A, Lazaros G, Andreis A, Scarsi M, Klein A, De Ferrari GM, Adler Y.

Sarcopenia and COVID-19: A Manifold Insight on Hypertension and the Renin Angiotensin System

Ekiz T, Kara M, Özcan F, Ricci V, Özçakar L.

Angiotensin-Converting Enzyme 2 as a Versatile Player in the Management of Coronavirus Disease 2019

Amano T.

Expecting the unexpected: Echo laboratory preparedness in the time of COVID-19

Goldberg AB, Kyung S, Swearingen S, Rao A.

A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock

Kim HN, Lee JH, Park HS, Yang DH, Jang SY, Bae MH, Cho Y, Chae SC, Lee YH.

Management of adult cardiac arrest in the COVID-19 era: consensus statement from the Australasian College for Emergency Medicine

Craig S, Cubitt M, Jaison A, Troupakis S, Hood N, Fong C, Bilgrami A, Leman P, Ascencio-Lane JC, Nagaraj G, Bonning J, Blecher G, Mitchell R, Burkett E, McCarthy SM, Rojek AM, Hansen K, Psihogios H, Allely P, Judkins S, Foong LH, Bernard S, Cameron PA.

Telehealth for Pediatric Cardiology Practitioners in the Time of COVID-19

Chowdhury D, Hope KD, Arthur LC, Weinberger SM, Ronai C, Johnson JN, Snyder CS.

Pulmonary embolism in COVID-19 patients: a French multicentre cohort study

Fauvel C, Weizman O, Trimaille A, Mika D, Pommier T, Pace N, Douair A, Barbin E, Fraix A, Bouchot O, Benmansour O, Godeau G, Mecheri Y, Lebourdon R, Yvorel C, Massin M, Leblon T, Chabbi C, Cugney E, Benabou L, Aubry M, Chan C, Boufoula I, Barnaud C, Bothorel L, Duceau B, Sutter W, Waldmann V, Bonnet G, Cohen A, Pezel T; Critical Covid-19 France Investigators.

COVID-19 and pulmonary embolism: an unwanted alliance

Torbicki A.

Acute Effusive Pericarditis: A Late Complication of COVID-19

Fox K, Prokup JA, Butson K, Jordan K.

In the eye of the storm: the right ventricle in COVID-19

Park JF, Banerjee S, Umar S.

Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients

Colafrancesco S, Scrivo R, Barbati C, Conti F, Priori R.

Cardiac Magnetic Resonance Characterization of Myocarditis-Like Acute Cardiac Syndrome in COVID-19

Esposito A, Palmisano A, Natale L, Ligabue G, Peretto G, Lovato L, Vignale D, Fiocchi F, Marano R, Russo V.

Right Ventricular Function and Pulmonary Pressures as Independent Predictors of Survival in Patients With COVID-19 Pneumonia

D'Andrea A, Scarafile R, Riegler L, Liccardo B, Crescibene F, Cocchia R, Bossone E.

Innovative Transthoracic Echocardiographic Imaging on Prone Ventilated Patients With COVID-19 Using a Transesophageal Probe

Marvaki A, Papachristidis A, Nakou E, Toth E, O'Gallagher K, Fisher R, Shah AM, Monaghan MJ.

Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19

Li Y, Li H, Zhu S, Xie Y, Wang B, He L, Zhang D, Zhang Y, Yuan H, Wu C, Sun W, Zhang Y, Li M, Cui L, Cai Y, Wang J, Yang Y, Lv Q, Zhang L, Xie M.

Epicardial Echocardiography-A Plausible Alternative Cardiac Imaging Technique in COVID-19 Pandemic

Senniappan K, Damodaran S, Kanchi M.

Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea

Son M, Seo J, Yang S.

Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients

Pan W, Zhang J, Wang M, Ye J, Xu Y, Shen B, He H, Wang Z, Ye D, Zhao M, Luo Z, Liu M, Zhang P, Gu J, Liu M, Li D, Liu J, Wan J.

Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-mediated Effects on Potassium Channel Expression

Lazzerini PE, Acampa M, Laghi-Pasini F, Bertolozzi I, Finizola F, Vanni F, Natale M, Bisogno S, Cevenini G, Cartocci A, Giabbani B, Migliacci N, D'Errico A, Dokollari A, Maccherini M, Boutjdir M, Capecchi PL.

Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients

Cameli M, Pastore MC, Soliman Aboumarie H, Mandoli GE, D'Ascenzi F, Cameli P, Bigio E, Franchi F, Mondillo S, Valente S.

Heart Transplantation in the Early Phase of the COVID-19 Pandemic: A Single-Center Case Series

Hsu JJ, Al-Saffar F, Ardehali R, Baas AS, Carlson M, Cruz D, Deng M, Fan A, Fraschilla S, Gaynor P, Kamath M, Kubak BM, Schaenman J, Stimpson E, Vucicevic D, Ardehali A, Nsair A.

Considerations on cardiac patients during Covid-19 outbreak

Sozzi FB, Belmonte M, Schiavone M, Canetta C, Blasi F.

QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin

C Hsia B, Greige N, A Quiroz J, S Khokhar A, Daily J, Di Biase L, J Ferrick K, D Fisher J, Krumerman A.

Out-of-hospital cardiac arrest during the COVID-19 pandemic in the Province of Padua, Northeast Italy

Paoli A, Brischigliaro L, Scquizzato T, Favaretto A, Spagna A.

Feasibility of a 5G-based robot-assisted remote ultrasound system for cardiopulmonary assessment of COVID-19 patients

Ye R, Zhou X, Shao F, Xiong L, Hong J, Huang H, Tong W, Wang J, Chen S, Cui A, Peng C, Zhao Y, Chen L.

Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities

Wang JJ, Edin ML, Zeldin DC, Li C, Wang DW, Chen C.

Reply to letters vide manuscript ID IPEJ-D-20-00072, and IPEJ-D-20-00073 regarding our paper "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm SocietyÀÆ

Kapoor A, Pandurangi U, Arora V, Gupta A, Jaswal A, Nabar A, Naik A, Naik N, Namboodiri Kk N, Vora A, Yadav R, Saxena A.

Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia

Vuorio A, Kovanen PT.

Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection

Hu X, Chen D, Wu L, He G, Ye W.

Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era

Massoomi MR, Anderson RD, Ahmed MM, Dasa O, George P Jr, Miles WM, Aranda JM Jr, Pepine CJ.

Cardiac surgery model during COVID-19 pandemic: now it's time to ramp up

Folesani G, Botta L, Pacini D.

Fulminant myocarditis and COVID-19. Response

Irabien-Ortiz Á, Carreras-Mora J, Sionis A, Tauron M.

Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia

Adikari DH, Kushwaha VV, Jepson NS.

Commentary: Fool me once, shame on you, fool me twice, shame on me-preparing for acute aortic emergencies and the next wave of the COVID-19 pandemic

Lau C, Gaudino M.

The Anesthetic Management of the First Lung Transplant for a Patient with COVID-19 Respiratory Failure

Hu C, Wang G, Zhou D, Wang W, Qin Z, Wang Y, Chen J, Liu H, Li Q, Huang D.

Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19

Funck-Brentano C, Nguyen LS, Salem JE.

Coronary artery bypass grafting surgery versus percutaneous coronary intervention: What is the clinical decision framework amid COVID-19 era?

Awad WI, Idhrees M, Kennon S, Bashir M.

Cardiac manifestations in COVID-19 patients-A systematic review

Shafi AMA, Shaikh SA, Shirke MM, Iddawela S, Harky A.

Cardiac surgery and COVID-19: Response to the letter to the editor

Hussain A.

The COVID-19 crisis: reflections on cardiothoracic surgery training

Fudulu DP, Angelini GD.

Cardiac surgery and COVID-19

Wiwanitkit V.

COVID and a call to reinventing medical education

Lattouf OM.